Keith Fox
#90,468
Most Influential Person Now
Researcher
Keith Fox's AcademicInfluence.com Rankings
Keith Foxengineering Degrees
Engineering
#2134
World Rank
#2986
Historical Rank
Electrical Engineering
#349
World Rank
#393
Historical Rank
Keith Foxcomputer-science Degrees
Computer Science
#3063
World Rank
#3213
Historical Rank
Computational Linguistics
#110
World Rank
#112
Historical Rank
Machine Learning
#288
World Rank
#292
Historical Rank
Artificial Intelligence
#464
World Rank
#473
Historical Rank
Download Badge
Engineering Computer Science
Keith Fox's Degrees
- PhD Computer Science Stanford University
- Masters Electrical Engineering University of California, Berkeley
- Bachelors Computer Engineering University of California, Berkeley
Similar Degrees You Can Earn
Why Is Keith Fox Influential?
(Suggest an Edit or Addition)Keith Fox's Published Works
Published Works
- Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. (2011) (5296)
- Third universal definition of myocardial infarction. (2012) (4123)
- Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study (2001) (2577)
- Universal definition of myocardial infarction. (2015) (2234)
- Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. (2006) (2183)
- Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology. (2008) (2081)
- Predictors of hospital mortality in the global registry of acute coronary events. (2003) (2077)
- Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study (2012) (2002)
- [Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes]. (2007) (1974)
- ISIS-4: A randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58 050 patients with suspected acute myocardial infarction (1995) (1755)
- Rivaroxaban in patients with a recent acute coronary syndrome. (2012) (1745)
- Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease (2017) (1499)
- A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group. (1997) (1423)
- Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE) (2006) (1396)
- Management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology. (2003) (1374)
- Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial. (2004) (1346)
- Adverse Impact of Bleeding on Prognosis in Patients With Acute Coronary Syndromes (2006) (1314)
- Prospective study of heart rate variability and mortality in chronic heart failure: results of the United Kingdom heart failure evaluation and assessment of risk trial (UK-heart). (1998) (1176)
- Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI. (2016) (1176)
- Comparison of fondaparinux and enoxaparin in acute coronary syndromes. (2006) (1125)
- A validated prediction model for all forms of acute coronary syndrome:estimating the risk of 6-month postdischarge death in an international registry (2004) (1084)
- Third universal definition of myocardial infarction. (2012) (921)
- Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. (2002) (920)
- ISIS-3 - A RANDOMIZED COMPARISON OF STREPTOKINASE VS TISSUE PLASMINOGEN-ACTIVATOR VS ANISTREPLASE AND OF ASPIRIN PLUS HEPARIN VS ASPIRIN ALONE AMONG 41,299 CASES OF SUSPECTED ACUTE MYOCARDIAL-INFARCTION (1992) (920)
- Decline in rates of death and heart failure in acute coronary syndromes, 1999-2006. (2007) (903)
- Effects of fondaparinux on mortality and reinfarction in patients with acute ST-segment elevation myocardial infarction: the OASIS-6 randomized trial. (2006) (855)
- Vorapaxar in the secondary prevention of atherothrombotic events. (2012) (839)
- Routine vs selective invasive strategies in patients with acute coronary syndromes: a collaborative meta-analysis of randomized trials. (2005) (827)
- Benefits and Risks of the Combination of Clopidogrel and Aspirin in Patients Undergoing Surgical Revascularization for Non–ST-Elevation Acute Coronary Syndrome: The Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) Trial (2004) (811)
- Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial (2010) (808)
- 18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial (2014) (784)
- Early versus delayed invasive intervention in acute coronary syndromes. (2009) (781)
- Third universal definition of myocardial infarction. (2012) (751)
- International Day for the Evaluation of Abdominal Obesity (IDEA): A Study of Waist Circumference, Cardiovascular Disease, and Diabetes Mellitus in 168 000 Primary Care Patients in 63 Countries (2007) (749)
- Effects of Aspirin Dose When Used Alone or in Combination With Clopidogrel in Patients With Acute Coronary Syndromes: Observations From the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) Study (2003) (743)
- A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry. (2004) (677)
- Baseline characteristics, management practices, and in-hospital outcomes of patients hospitalized with acute coronary syndromes in the Global Registry of Acute Coronary Events (GRACE). (2002) (675)
- Color Doppler myocardial imaging: a new technique for the assessment of myocardial function. (1994) (643)
- Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial. (2007) (625)
- Association of Diet, Exercise, and Smoking Modification With Risk of Early Cardiovascular Events After Acute Coronary Syndromes (2010) (625)
- Management of acute coronary syndromes. Variations in practice and outcome; findings from the Global Registry of Acute Coronary Events (GRACE). (2002) (607)
- Impact of age on management and outcome of acute coronary syndrome: observations from the Global Registry of Acute Coronary Events (GRACE). (2005) (596)
- Prevention of stroke and systemic embolism with rivaroxaban compared with warfarin in patients with non-valvular atrial fibrillation and moderate renal impairment. (2011) (591)
- MANAGEMENT OF ACUTE MYOCARDIAL INFARCTION IN PATIENTS PRESENTING WITH PERSISTENT ST-SEGMENT ELEVATION (ENDING) (2009) (590)
- Predictors of major bleeding in acute coronary syndromes: the Global Registry of Acute Coronary Events (GRACE). (2004) (586)
- Aspirin for prevention of cardiovascular events in a general population screened for a low ankle brachial index: a randomized controlled trial. (2010) (569)
- Dose comparisons of clopidogrel and aspirin in acute coronary syndromes. (2010) (549)
- Effects of CYP2C19 genotype on outcomes of clopidogrel treatment. (2010) (545)
- Long-term outcome of a routine versus selective invasive strategy in patients with non-ST-segment elevation acute coronary syndrome a meta-analysis of individual patient data. (2010) (544)
- Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with stable angina requiring treatment (ACTION trial): randomised controlled trial (2004) (508)
- Apixaban, an Oral, Direct, Selective Factor Xa Inhibitor, in Combination With Antiplatelet Therapy After Acute Coronary Syndrome: Results of the Apixaban for Prevention of Acute Ischemic and Safety Events (APPRAISE) Trial (2009) (486)
- Prasugrel versus clopidogrel for acute coronary syndromes without revascularization. (2012) (481)
- Early invasive vs conservative treatment strategies in women and men with unstable angina and non-ST-segment elevation myocardial infarction: a meta-analysis. (2008) (465)
- Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial (2017) (464)
- Evacetrapib and Cardiovascular Outcomes in High‐Risk Vascular Disease (2017) (462)
- Enoxaparin versus unfractionated heparin with fibrinolysis for ST-elevation myocardial infarction. (2006) (452)
- Underestimated and under-recognized: the late consequences of acute coronary syndrome (GRACE UK-Belgian Study). (2010) (422)
- Management of acute coronary syndromes: acute coronary syndromes without persistent ST segment elevation; recommendations of the Task Force of the European Society of Cardiology. (2000) (418)
- The relation between quantitative right ventricular ejection fraction and indices of tricuspid annular motion and myocardial performance. (2004) (413)
- Endothelial dysfunction, impaired endogenous fibrinolysis, and cigarette smoking: a mechanism for arterial thrombosis and myocardial infarction. (1999) (413)
- Predictors of major bleeding in acute coronary syndromes: the Global Registry of Acute Coronary Events (GRACE) (2003) (391)
- Quantification of regional myocardial blood flow in vivo with H215O. (1984) (389)
- Seven-year outcome in the RITA-2 trial: coronary angioplasty versus medical therapy. (2003) (384)
- Combination antithrombotic therapy in unstable rest angina and non-Q-wave infarction in nonprior aspirin users. Primary end points analysis from the ATACS trial. Antithrombotic Therapy in Acute Coronary Syndromes Research Group. (1994) (372)
- High sensitivity cardiac troponin and the under-diagnosis of myocardial infarction in women: prospective cohort study (2015) (372)
- Increased Platelet Binding to Circulating Monocytes in Acute Coronary Syndromes (2002) (367)
- Bleeding in acute coronary syndromes and percutaneous coronary interventions: position paper by the Working Group on Thrombosis of the European Society of Cardiology. (2011) (364)
- Intervention in acute coronary syndromes: do patients undergo intervention on the basis of their risk characteristics? The Global Registry of Acute Coronary Events (GRACE) (2005) (356)
- Coronary thrombolysis with tissue-type plasminogen activator in patients with evolving myocardial infarction. (1984) (355)
- A comparison of hirudin with heparin in the prevention of restenosis after coronary angioplasty. Helvetica Investigators. (1995) (350)
- Implementation of a sensitive troponin I assay and risk of recurrent myocardial infarction and death in patients with suspected acute coronary syndrome. (2011) (342)
- Rivaroxaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of ROCKET AF (2012) (335)
- Early and Late Effects of Clopidogrel in Patients With Acute Coronary Syndromes (2003) (311)
- Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trial. (1999) (311)
- Creatinine clearance and adverse hospital outcomes in patients with acute coronary syndromes: findings from the global registry of acute coronary events (GRACE) (2003) (306)
- Differences in the management and prognosis of women and men who suffer from acute coronary syndromes. (2005) (292)
- Outcomes after cardioversion and atrial fibrillation ablation in patients treated with rivaroxaban and warfarin in the ROCKET AF trial. (2013) (286)
- Higher risk of death and stroke in patients with persistent vs. paroxysmal atrial fibrillation: results from the ROCKET-AF Trial (2014) (281)
- Impaired Coronary Tissue Plasminogen Activator Release Is Associated With Coronary Atherosclerosis and Cigarette Smoking: Direct Link Between Endothelial Dysfunction and Atherothrombosis (2001) (279)
- Trends in acute reperfusion therapy for ST-segment elevation myocardial infarction from 1999 to 2006: we are getting better but we have got a long way to go. (2008) (275)
- Efficacy and safety of fondaparinux versus enoxaparin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: results from the OASIS-5 trial. (2007) (274)
- From guidelines to clinical practice: the impact of hospital and geographical characteristics on temporal trends in the management of acute coronary syndromes. The Global Registry of Acute Coronary Events (GRACE). (2003) (263)
- Should patients with acute coronary disease be stratified for management according to their risk? Derivation, external validation and outcomes using the updated GRACE risk score (2014) (258)
- Clot-selective coronary thrombolysis with tissue-type plasminogen activator. (1983) (253)
- Comparison of sibrafiban with aspirin for prevention of cardiovascular events after acute coronary syndromes: a randomised trial (2000) (252)
- The Global Registry of Acute Coronary Events, 1999 to 2009–GRACE (2010) (250)
- Safety of Proton Pump Inhibitors Based on a Large, Multi-year, Randomized Trial of Patients Receiving Rivaroxaban or Aspirin. (2019) (249)
- The ENACT study: a pan-European survey of acute coronary syndromes. European Network for Acute Coronary Treatment. (2000) (247)
- Benefit of Clopidogrel in Patients With Acute Coronary Syndromes Without ST-Segment Elevation in Various Risk Groups (2002) (245)
- Does Comorbidity Account for the Excess Mortality in Patients With Major Bleeding in Acute Myocardial Infarction? (2007) (243)
- Rimonabant for prevention of cardiovascular events (CRESCENDO): a randomised, multicentre, placebo-controlled trial (2010) (238)
- The effect of interleukin-1 receptor antagonist therapy on markers of inflammation in non-ST elevation acute coronary syndromes: the MRC-ILA Heart Study (2013) (235)
- Impact of Global Geographic Region on Time in Therapeutic Range on Warfarin Anticoagulant Therapy: Data From the ROCKET AF Clinical Trial (2013) (231)
- Platelet function during extended prasugrel and clopidogrel therapy for patients with ACS treated without revascularization: the TRILOGY ACS platelet function substudy. (2012) (231)
- Prognostic value of serial B-type natriuretic peptide testing during follow-up of patients with unstable coronary artery disease. (2005) (229)
- Major Adverse Limb Events and Mortality in Patients With Peripheral Artery Disease: The COMPASS Trial. (2018) (229)
- Differences in myocardial velocity gradient measured throughout the cardiac cycle in patients with hypertrophic cardiomyopathy, athletes and patients with left ventricular hypertrophy due to hypertension. (1997) (223)
- Predicting death due to progressive heart failure in patients with mild-to-moderate chronic heart failure. (2002) (222)
- Factors associated with major bleeding events: insights from the ROCKET AF trial (rivaroxaban once-daily oral direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation). (2014) (215)
- Incomplete Inhibition of Thromboxane Biosynthesis by Acetylsalicylic Acid: Determinants and Effect on Cardiovascular Risk (2008) (215)
- Clinical outcomes, risk stratification and practice patterns of unstable angina and myocardial infarction without ST elevation: Prospective Registry of Acute Ischaemic Syndromes in the UK (PRAIS-UK) (2000) (214)
- Two-year outcomes of patients with newly diagnosed atrial fibrillation: results from GARFIELD-AF (2016) (214)
- Temporal dependence of beneficial effects of coronary thrombolysis characterized by positron tomography. (1982) (214)
- Safety and efficacy of enoxaparin vs unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes who receive tirofiban and aspirin: a randomized controlled trial. (2004) (208)
- Resolving inequalities in care? Reduced mortality in the elderly after acute coronary syndromes. The Myocardial Ischaemia National Audit Project 2003-2010. (2012) (205)
- Association of Statin Therapy with Outcomes of Acute Coronary Syndromes: The GRACE Study (2004) (205)
- Six-month outcomes in a multinational registry of patients hospitalized with an acute coronary syndrome (the Global Registry of Acute Coronary Events [GRACE]). (2004) (204)
- High-sensitivity troponin in the evaluation of patients with suspected acute coronary syndrome: a stepped-wedge, cluster-randomised controlled trial (2018) (201)
- The expanded Global Registry of Acute Coronary Events: baseline characteristics, management practices, and hospital outcomes of patients with acute coronary syndromes. (2009) (199)
- Coronary thrombolysis with intravenously administered human tissue-type plasminogen activator produced by recombinant DNA technology. (1984) (189)
- Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation The Task Force on the Management of Acute Coronary Syndromes of the European Society of Cardiology* (2002) (187)
- Relationship of treatment delays and mortality in patients undergoing fibrinolysis and primary percutaneous coronary intervention. The Global Registry of Acute Coronary Events (2006) (187)
- Evaluation of a novel antiplatelet agent for secondary prevention in patients with a history of atherosclerotic disease: design and rationale for the Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events (TRA 2 degrees P)-TIMI 50 trial. (2009) (184)
- Antithrombotic therapy in the elderly: expert position paper of the European Society of Cardiology Working Group on Thrombosis. (2015) (183)
- Improving clinical outcomes by reducing bleeding in patients with non-ST-elevation acute coronary syndromes. (2008) (182)
- Effect of Losmapimod on Cardiovascular Outcomes in Patients Hospitalized With Acute Myocardial Infarction: A Randomized Clinical Trial. (2016) (179)
- Clinical characteristics and outcomes with rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation but underlying native mitral and aortic valve disease participating in the ROCKET AF trial (2014) (177)
- Intracranial Hemorrhage Among Patients With Atrial Fibrillation Anticoagulated With Warfarin or Rivaroxaban: The Rivaroxaban Once Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (2014) (173)
- Primacy of the 3B approach to control risk factors for cardiovascular disease in type 2 diabetes patients. (2013) (164)
- Management of major bleeding events in patients treated with rivaroxaban vs. warfarin: results from the ROCKET AF trial. (2014) (162)
- An open-label, randomized, controlled, multicenter study exploring two treatment strategies of rivaroxaban and a dose-adjusted oral vitamin K antagonist treatment strategy in subjects with atrial fibrillation who undergo percutaneous coronary intervention (PIONEER AF-PCI). (2015) (162)
- β-Blockers and Mortality After Acute Myocardial Infarction in Patients Without Heart Failure or Ventricular Dysfunction (2017) (162)
- Randomized trial of low molecular weight heparin (enoxaparin) versus unfractionated heparin for unstable coronary artery disease: one-year results of the ESSENCE Study. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q Wave Coronary Events. (2000) (160)
- Comparison of outcomes of patients with acute coronary syndromes with and without atrial fibrillation. (2003) (159)
- Gastrointestinal Bleeding in Patients With Atrial Fibrillation Treated With Rivaroxaban or Warfarin: ROCKET AF Trial. (2015) (157)
- Does Simplicity Compromise Accuracy in ACS Risk Prediction? A Retrospective Analysis of the TIMI and GRACE Risk Scores (2009) (156)
- MRC BHFHeart Protection Study of cholesterol-lowering therapy and of antioxidant vitamin supplementation in a wide range of patients at increased risk of coronary heart disease death: early safety and efficacy experience (1999) (156)
- Ultrasmall Superparamagnetic Particles of Iron Oxide in Patients With Acute Myocardial Infarction: Early Clinical Experience (2012) (155)
- International trends in clinical characteristics and oral anticoagulation treatment for patients with atrial fibrillation: Results from the GARFIELD‐AF, ORBIT‐AF I, and ORBIT‐AF II registries (2017) (154)
- Design and rationale of CURRENT-OASIS 7: a randomized, 2 x 2 factorial trial evaluating optimal dosing strategies for clopidogrel and aspirin in patients with ST and non-ST-elevation acute coronary syndromes managed with an early invasive strategy. (2008) (153)
- Do we need additional markers of myocyte necrosis: the potential value of heart fatty-acid-binding protein. (2004) (151)
- Cause of Death and Predictors of All‐Cause Mortality in Anticoagulated Patients With Nonvalvular Atrial Fibrillation: Data From ROCKET AF (2016) (149)
- Efflux of metabolized and nonmetabolized fatty acid from canine myocardium. Implications for quantifying myocardial metabolism tomographically. (1985) (149)
- Positron emission tomography of the heart. (1992) (144)
- Rivaroxaban for Stroke Prevention in East Asian Patients From the ROCKET AF Trial (2014) (144)
- Myocardial infarction redefined: the new ACC/ESC definition, based on cardiac troponin, increases the apparent incidence of infarction (2002) (143)
- Sensitive Troponin Assay and the Classification of Myocardial Infarction (2015) (142)
- Circulating secretory phospholipase A2 activity predicts recurrent events in patients with severe acute coronary syndromes. (2005) (142)
- [Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation]. (2009) (140)
- Effects of captopril therapy on endogenous fibrinolysis in men with recent, uncomplicated myocardial infarction. (1994) (139)
- Effects of aspirin dose on ischaemic events and bleeding after percutaneous coronary intervention: insights from the PCI-CURE study. (2008) (137)
- Changing Characteristics and Mode of Death Associated With Chronic Heart Failure Caused by Left Ventricular Systolic Dysfunction: A Study Across Therapeutic Eras (2011) (136)
- Rationale, Design and Baseline Characteristics of Participants in the Cardiovascular Outcomes for People Using Anticoagulation Strategies (COMPASS) Trial. (2017) (133)
- Effect of "fast track" admission for acute myocardial infarction on delay to thrombolysis. (1992) (132)
- Smoking, Clopidogrel, and Mortality in Patients With Established Cardiovascular Disease (2009) (131)
- Intra-Arterial Tumor Necrosis Factor-&agr; Impairs Endothelium-Dependent Vasodilatation and Stimulates Local Tissue Plasminogen Activator Release in Humans (2003) (130)
- Renal Dysfunction as a Predictor of Stroke and Systemic Embolism in Patients With Nonvalvular Atrial FibrillationClinical Perspective (2013) (130)
- Elderly Patients With Acute Coronary Syndromes Managed Without Revascularization: Insights Into the Safety of Long-Term Dual Antiplatelet Therapy With Reduced-Dose Prasugrel Versus Standard-Dose Clopidogrel (2013) (129)
- Bradykinin Contributes to the Vasodilator Effects of Chronic Angiotensin-Converting Enzyme Inhibition in Patients With Heart Failure (2001) (128)
- Lack of evidence of a clopidogrel-statin interaction in the CHARISMA trial. (2006) (128)
- On-Treatment Outcomes in Patients With Worsening Renal Function With Rivaroxaban Compared With Warfarin: Insights From ROCKET AF (2015) (127)
- Polypharmacy and the Efficacy and Safety of Rivaroxaban Versus Warfarin in the Prevention of Stroke in Patients With Nonvalvular Atrial Fibrillation (2016) (127)
- Access to catheterisation facilities in patients admitted with acute coronary syndrome: multinational registry study (2005) (127)
- Characterisation of coronary atherosclerotic morphology by spectral analysis of radiofrequency signal: in vitro intravascular ultrasound study with histological and radiological validation (1998) (126)
- Mortality following placement of drug-eluting and bare-metal stents for ST-segment elevation acute myocardial infarction in the Global Registry of Acute Coronary Events. (2008) (126)
- Risk score for predicting death, myocardial infarction, and stroke in patients with stable angina, based on a large randomised trial cohort of patients (2005) (125)
- Global patterns of use of antithrombotic and antiplatelet therapies in patients with acute coronary syndromes: insights from the Global Registry of Acute Coronary Events (GRACE). (2003) (125)
- Age-related transmural peak mean velocities and peak velocity gradients by Doppler myocardial imaging in normal subjects. (1996) (124)
- Study design and rationale of a comparison of prasugrel and clopidogrel in medically managed patients with unstable angina/non-ST-segment elevation myocardial infarction: the TaRgeted platelet Inhibition to cLarify the Optimal strateGy to medicallY manage Acute Coronary Syndromes (TRILOGY ACS) trial (2010) (122)
- Clinical outcomes of patients with diabetic nephropathy randomized to clopidogrel plus aspirin versus aspirin alone (a post hoc analysis of the clopidogrel for high atherothrombotic risk and ischemic stabilization, management, and avoidance [CHARISMA] trial). (2009) (119)
- Prasugrel versus clopidogrel for patients with unstable angina or non-ST-segment elevation myocardial infarction with or without angiography: a secondary, prespecified analysis of the TRILOGY ACS trial (2013) (118)
- Randomized, Blinded Trial Comparing Fondaparinux With Unfractionated Heparin in Patients Undergoing Contemporary Percutaneous Coronary Intervention: Arixtra Study in Percutaneous Coronary Intervention: A Randomized Evaluation (ASPIRE) Pilot Trial (2005) (118)
- Prevention of coronary thrombosis with subthrombolytic doses of tissue-type plasminogen activator. (1985) (116)
- A randomised study of home-based electrical stimulation of the legs and conventional bicycle exercise training for patients with chronic heart failure. (2003) (116)
- Risk prediction in patients presenting with suspected cardiac pain: the GRACE and TIMI risk scores versus clinical evaluation. (2006) (116)
- Health-related quality of life after interventional or conservative strategy in patients with unstable angina or non-ST-segment elevation myocardial infarction: one-year results of the third Randomized Intervention Trial of unstable Angina (RITA-3). (2005) (116)
- Rationale and design of ACTIVE: the atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events. (2006) (115)
- In-hospital mortality after out-of-hospital cardiac arrest (1995) (114)
- Frailty is associated with worse outcomes in non-ST-segment elevation acute coronary syndromes: Insights from the TaRgeted platelet Inhibition to cLarify the Optimal strateGy to medicallY manage Acute Coronary Syndromes (TRILOGY ACS) trial (2016) (113)
- Efficacy and safety of rivaroxaban in patients with diabetes and nonvalvular atrial fibrillation: the Rivaroxaban Once-daily, Oral, Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF Trial). (2015) (112)
- Association of elevated fasting glucose with increased short-term and 6-month mortality in ST-segment elevation and non-ST-segment elevation acute coronary syndromes: the Global Registry of Acute Coronary Events. (2009) (111)
- Increased CD40 ligand and platelet-monocyte aggregates in patients with type 1 diabetes mellitus. (2004) (111)
- Influence of Renal Function on the Efficacy and Safety of Fondaparinux Relative to Enoxaparin in NonST-Segment Elevation Acute Coronary Syndromes (2007) (107)
- The relationship between CYP2C19 polymorphisms and ischaemic and bleeding outcomes in stable outpatients: the CHARISMA genetics study. (2012) (107)
- An in vivo Model for the Assessment of Acute Fibrinolytic Capacity of the Endothelium (1997) (107)
- Effects of age on long-term outcomes after a routine invasive or selective invasive strategy in patients presenting with non-ST segment elevation acute coronary syndromes: a collaborative analysis of individual data from the FRISC II - ICTUS - RITA-3 (FIR) trials (2011) (107)
- Implications of lowering threshold of plasma troponin concentration in diagnosis of myocardial infarction: cohort study (2012) (107)
- The diagnostic and prognostic impact of the redefinition of acute myocardial infarction: lessons from the Global Registry of Acute Coronary Events (GRACE). (2006) (107)
- Efficacy and Safety of Rivaroxaban in Patients With Heart Failure and Nonvalvular Atrial Fibrillation: Insights From ROCKET AF (2013) (106)
- Contemporary management of acute coronary syndromes: does the practice match the evidence? The global registry of acute coronary events (GRACE) (2005) (106)
- Ethnic variation in adverse cardiovascular outcomes and bleeding complications in the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) study. (2009) (104)
- Memory impairment in out-of-hospital cardiac arrest survivors is associated with global reduction in brain volume, not focal hippocampal injury. (2000) (104)
- Reperfusion strategy in Europe: temporal trends in performance measures for reperfusion therapy in ST-elevation myocardial infarction. (2010) (104)
- Magnitude of and Risk Factors for In-Hospital and Postdischarge Stroke in Patients With Acute Coronary Syndromes: Findings From a Global Registry of Acute Coronary Events (2005) (102)
- Do men benefit more than women from an interventional strategy in patients with unstable angina or non-ST-elevation myocardial infarction? The impact of gender in the RITA 3 trial. (2004) (101)
- The impact of renal dysfunction on outcomes in the ExTRACT-TIMI 25 trial. (2007) (100)
- Clopidogrel discontinuation after acute coronary syndromes: frequency, predictors and associations with death and myocardial infarction—a hospital registry-primary care linked cohort (MINAP–GPRD) (2011) (100)
- [Expert Consensus document on angiotensin converting enzyme inhibitors in cardiovascular disease]. (2004) (100)
- Long-Term Cardiovascular Mortality After Procedure-Related or Spontaneous Myocardial Infarction in Patients With Non–ST-Segment Elevation Acute Coronary Syndrome: A Collaborative Analysis of Individual Patient Data From the FRISC II, ICTUS, and RITA-3 Trials (FIR) (2012) (100)
- Relationship Between Time in Therapeutic Range and Comparative Treatment Effect of Rivaroxaban and Warfarin: Results From the ROCKET AF Trial (2014) (99)
- Prediction of cognitive dysfunction after resuscitation from out-of-hospital cardiac arrest using serum neuron-specific enolase and protein S-100 (2007) (99)
- Low-molecular-weight heparins in non–ST-segment elevation ischemia: the ESSENCE trial (1998) (99)
- Enoxaparin versus unfractionated heparin as antithrombin therapy in patients receiving fibrinolysis for ST-elevation myocardial infarction. Design and rationale for the Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment-Thrombolysis In Myocardial Infarction study 25 (E (2005) (98)
- Recurrent Hospitalization Among Patients With Atrial Fibrillation Undergoing Intracoronary Stenting Treated With 2 Treatment Strategies of Rivaroxaban or a Dose-Adjusted Oral Vitamin K Antagonist Treatment Strategy (2017) (98)
- High-Sensitivity Cardiac Troponin and the Universal Definition of Myocardial Infarction (2019) (96)
- Quality indicators for acute myocardial infarction: A position paper of the Acute Cardiovascular Care Association (2017) (96)
- The relationship between QT intervals and mortality in ambulant patients with chronic heart failure. The united kingdom heart failure evaluation and assessment of risk trial (UK-HEART) (1999) (95)
- Chronic memory impairment after cardiac arrest outside hospital (1996) (95)
- Medication performance measures and mortality following acute coronary syndromes. (2005) (94)
- Early increase in levels of soluble inter-cellular adhesion molecule-1 (sICAM-1); potential risk factor for the acute coronary syndromes. (2001) (94)
- An invasive or conservative strategy in patients with diabetes mellitus and non-ST-segment elevation acute coronary syndromes: a collaborative meta-analysis of randomized trials. (2012) (93)
- Change in circulating cytokines after 2 forms of exercise training in chronic stable heart failure. (2004) (91)
- Population pharmacokinetics and pharmacodynamics of rivaroxaban in patients with non‐valvular atrial fibrillation: Results from ROCKET AF (2014) (90)
- Thyroid disease and increased cardiovascular risk. (2005) (88)
- Quantitative troponin and death, cardiogenic shock, cardiac arrest and new heart failure in patients with non-ST-segment elevation acute coronary syndromes (NSTE ACS): insights from the Global Registry of Acute Coronary Events (2010) (88)
- &bgr;-Blockers and Cardiovascular Events in Patients With and Without Myocardial Infarction: Post Hoc Analysis From the CHARISMA Trial (2014) (87)
- Raised plasma endothelin in unstable angina and non-Q wave myocardial infarction: relation to cardiovascular outcome. (1994) (87)
- Reperfusion in patients with renal dysfunction after presentation with ST-segment elevation or left bundle branch block: GRACE (Global Registry of Acute Coronary Events). (2009) (87)
- Systemic Atherosclerotic Inflammation Following Acute Myocardial Infarction: Myocardial Infarction Begets Myocardial Infarction (2015) (86)
- Trends in hospital treatments, including revascularisation, following acute myocardial infarction, 2003–2010: a multilevel and relative survival analysis for the National Institute for Cardiovascular Outcomes Research (NICOR) (2013) (86)
- Flow cytometric analysis of circulating platelet-monocyte aggregates in whole blood: Methodological considerations (2007) (86)
- Relationship between baseline haemoglobin and major bleeding complications in acute coronary syndromes. (2010) (86)
- British Cardiac Society Working Group on the definition of myocardial infarction (2004) (86)
- Ischaemic cardiac outcomes in patients with atrial fibrillation treated with vitamin K antagonism or factor Xa inhibition: results from the ROCKET AF trial. (2014) (83)
- Validity of a risk-prediction tool for hospital mortality: the Global Registry of Acute Coronary Events. (2009) (83)
- Antithrombotic therapy and body mass: an expert position paper of the ESC Working Group on Thrombosis. (2018) (83)
- Rivaroxaban Plus Aspirin Versus Aspirin in Relation to Vascular Risk in the COMPASS Trial. (2019) (83)
- Effects of long-term, moderate-intensity oral anticoagulation in addition to aspirin in unstable angina (2001) (83)
- Efficacy and safety of rivaroxaban compared with warfarin in patients with peripheral artery disease and non-valvular atrial fibrillation: insights from ROCKET AF. (2013) (83)
- Predicting freedom from clinical events in non-ST-elevation acute coronary syndromes: the Global Registry of Acute Coronary Events (2009) (82)
- Late Consequences of Acute Coronary Syndromes: Global Registry of Acute Coronary Events (GRACE) Follow-up. (2015) (80)
- Secretory phospholipase A(2)-IIA and cardiovascular disease: a mendelian randomization study. (2013) (80)
- Pantoprazole to Prevents Gastroduodenal Events in Patients Receiving Rivaroxaban and/or Aspirin in a Randomized, Double-blind, Placebo-controlled Trial. (2019) (79)
- Time course of events in acute coronary syndromes: implications for clinical practice from the GRACE registry (2008) (79)
- Safe use of platelet GP IIb/IIIa inhibitors. (1998) (79)
- Efficacy and safety of fondaparinux versus enoxaparin in patients with acute coronary syndromes treated with glycoprotein IIb/IIIa inhibitors or thienopyridines: results from the OASIS 5 (Fifth Organization to Assess Strategies in Ischemic Syndromes) trial. (2009) (79)
- The continuum of personalized cardiovascular medicine: a position paper of the European Society of Cardiology (2014) (79)
- The continuum of personalized cardiovascular medicine: a position paper of the European Society of Cardiology (2014) (79)
- In vitro analysis of coronary atheromatous lesions by intravascular ultrasound; reproducibility and histological correlation of lesion morphology. (1999) (78)
- Influence of age on use of cardiac catheterization and associated outcomes in patients with non-ST-elevation acute coronary syndromes. (2009) (78)
- [Fourth universal definition of myocardial infarction (2018)]. (2018) (78)
- Improved risk stratification of patients with atrial fibrillation: an integrated GARFIELD-AF tool for the prediction of mortality, stroke and bleed in patients with and without anticoagulation (2017) (78)
- Secretory Phospholipase A2-IIA and Cardiovascular Disease (2013) (78)
- Altered platelet function detected by flow cytometry. Effects of coronary artery disease and age. (1997) (78)
- An analysis of mortality rates with dual-antiplatelet therapy in the primary prevention population of the CHARISMA trial. (2007) (77)
- Effectiveness of primary percutaneous coronary intervention compared with that of thrombolytic therapy in elderly patients with acute myocardial infarction. (2004) (77)
- Euro Heart Survey 2009 Snapshot: regional variations in presentation and management of patients with AMI in 47 countries (2013) (77)
- Risk factors for death, stroke, and bleeding in 28,628 patients from the GARFIELD-AF registry: Rationale for comprehensive management of atrial fibrillation (2018) (77)
- Chronic nitrate therapy is associated with different presentation and evolution of acute coronary syndromes: insights from 52,693 patients in the Global Registry of Acute Coronary Events. (2010) (76)
- External applicability of the COMPASS trial: an analysis of the reduction of atherothrombosis for continued health (REACH) registry (2018) (76)
- Diesel exhaust inhalation does not affect heart rhythm or heart rate variability (2010) (75)
- Effect of Low-Dose Intracoronary Alteplase During Primary Percutaneous Coronary Intervention on Microvascular Obstruction in Patients With Acute Myocardial Infarction: A Randomized Clinical Trial (2019) (75)
- Strengths and weaknesses of ‘real-world’ studies involving non-vitamin K antagonist oral anticoagulants (2018) (74)
- Impact of hospital proportion and volume on primary percutaneous coronary intervention performance in England and Wales. (2011) (74)
- Metabolic fate of radiolabeled palmitate in ischemic canine myocardium: implications for positron emission tomography. (1987) (74)
- Oestrous synchronization and pregnancy blocking in wild house mice (Mus musculus). (1966) (74)
- Assessment of the clinical effects of cholesteryl ester transfer protein inhibition with evacetrapib in patients at high-risk for vascular outcomes: Rationale and design of the ACCELERATE trial. (2015) (74)
- Association of Clinical Factors and Therapeutic Strategies With Improvements in Survival Following Non-ST-Elevation Myocardial Infarction, 2003-2013. (2016) (74)
- ESC guidelines on management of acute myocardial infarction in patients presenting with persistent ST-segment elevation. (2009) (73)
- Performance of hospitals according to the ESC ACCA quality indicators and 30-day mortality for acute myocardial infarction: national cohort study using the United Kingdom Myocardial Ischaemia National Audit Project (MINAP) register (2017) (72)
- Evaluation of the NICE mini-GRACE risk scores for acute myocardial infarction using the Myocardial Ischaemia National Audit Project (MINAP) 2003–2009: National Institute for Cardiovascular Outcomes Research (NICOR) (2012) (72)
- Investigation of the effect of Interleukin-1 receptor antagonist (IL-1ra) on markers of inflammation in non-ST elevation acute coronary syndromes (The MRC-ILA-HEART Study) (2008) (72)
- Efficacy and Safety of Vorapaxar as Approved for Clinical Use in the United States (2015) (71)
- Resuscitation from out-of-hospital cardiac arrest: implications for cardiac enzyme estimation. (1996) (71)
- Benefit of clopidogrel according to timing of percutaneous coronary intervention in patients with acute coronary syndromes: further results from the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) study. (2005) (70)
- Enhancement of salvage of reperfused ischemic myocardium by diltiazem. (1986) (70)
- Effect of Clopidogrel plus ASA vs. ASA Early after TIA and Ischaemic Stroke: A Substudy of the CHARISMA Trial (2011) (69)
- Rivaroxaban With or Without Aspirin in Patients With Heart Failure and Chronic Coronary or Peripheral Artery Disease (2019) (69)
- Interventional vs. conservative treatment for patients with unstable angina or non-ST-elevation myocardial infarction: the british heart foundation RITA 3 randomized trial☆ (2003) (68)
- Multimorbidity and survival for patients with acute myocardial infarction in England and Wales: Latent class analysis of a nationwide population-based cohort (2018) (68)
- The 2010 ESC/EACTS guidelines on myocardial revascularisation (2010) (68)
- Has the frequency of bleeding changed over time for patients presenting with an acute coronary syndrome? The Global Registry of Acute Coronary Events (2009) (68)
- The myth of ‘stable’ coronary artery disease (2019) (67)
- Cardiac markers in the early diagnosis and management of patients with acute coronary syndrome. (2009) (67)
- The L-arginine/nitric oxide pathway contributes to the acute release of tissue plasminogen activator in vivo in man. (1998) (66)
- Neutral Endopeptidase Inhibition Augments Vascular Actions of Bradykinin in Patients Treated With Angiotensin-Converting Enzyme Inhibition (2004) (66)
- Rivaroxaban, Aspirin, or Both to Prevent Early Coronary Bypass Graft Occlusion: The COMPASS-CABG Study. (2019) (65)
- Stroke Outcomes in the COMPASS Trial (2019) (65)
- Does abdominal obesity have a similar impact on cardiovascular disease and diabetes? A study of 91,246 ambulant patients in 27 European countries. (2009) (65)
- Efficacy and safety of rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation and a history of cancer: observations from ROCKET AF (2018) (64)
- A variant at chromosome 9p21 is associated with recurrent myocardial infarction and cardiac death after acute coronary syndrome: the GRACE Genetics Study. (2010) (64)
- Delay to reperfusion in patients with acute myocardial infarction presenting to acute care hospitals: an international perspective. (2010) (64)
- A prognostic index to predict long‐term mortality in patients with mild to moderate chronic heart failure stabilised on angiotensin converting enzyme inhibitors (2003) (63)
- Age and sex differences, and changing trends, in the use of evidence-based therapies in acute coronary syndromes: perspectives from a multinational registry (2010) (63)
- The role of fondaparinux as an adjunct to thrombolytic therapy in acute myocardial infarction: a subgroup analysis of the OASIS-6 trial. (2008) (63)
- Color Doppler myocardial imaging (1994) (62)
- Prehospital Delay in Patients With Acute Coronary Syndromes (from the Global Registry of Acute Coronary Events [GRACE]). (2009) (62)
- Heart rate turbulence and death due to cardiac decompensation in patients with chronic heart failure (2006) (62)
- Prognosis in heart failure with preserved left ventricular systolic function: prospective cohort study (2003) (61)
- Clinical Outcomes With Rivaroxaban in Patients Transitioned From Vitamin K Antagonist Therapy (2013) (61)
- Classification of arterial plaque by spectral analysis of in vitro radio frequency intravascular ultrasound data. (2000) (61)
- Psychological factors associated with delay in attending hospital following a myocardial infarction. (2001) (60)
- In vitro acoustic characterisation of four intravenous ultrasonic contrast agents at 30 MHz. (2002) (60)
- Outcomes among non-ST-segment elevation acute coronary syndromes patients with no angiographically obstructive coronary artery disease: observations from 37,101 patients (2014) (59)
- Risk stratification in non-ST-segment elevation acute coronary syndromes: troponin alone is not enough. (2009) (59)
- 10-Year Mortality Outcome of a Routine Invasive Strategy Versus a Selective Invasive Strategy in Non-ST-Segment Elevation Acute Coronary Syndrome: The British Heart Foundation RITA-3 Randomized Trial. (2015) (59)
- Combination Antiplatelet and Oral Anticoagulant Therapy in Patients With Coronary and Peripheral Artery Disease: Focus on the COMPASS Trial (2019) (58)
- Dual-pathway inhibition for secondary and tertiary antithrombotic prevention in cardiovascular disease (2020) (58)
- Guía de Práctica Clínica para el diagnóstico y tratamiento del síndrome coronario agudo sin elevación del segmento ST (2007) (58)
- Characterisation of atherosclerotic plaque by spectral analysis of intravascular ultrasound: an in vitro methodology. (1997) (57)
- High-grade atrioventricular block in acute coronary syndromes: insights from the Global Registry of Acute Coronary Events. (2015) (57)
- The BEAUTIFUL Study: Randomized Trial of Ivabradine in Patients with Stable Coronary Artery Disease and Left Ventricular Systolic Dysfunction – Baseline Characteristics of the Study Population (2007) (56)
- Memory function in patients with stable, moderate to severe cardiac failure. (2000) (56)
- Design and rationale of the MICHELANGELO Organization to Assess Strategies in Acute Ischemic Syndromes (OASIS)-5 trial program evaluating fondaparinux, a synthetic factor Xa inhibitor, in patients with non-ST-segment elevation acute coronary syndromes. (2005) (56)
- The Uncoupling of Monocyte–Platelet Interactions from the Induction of Proinflammatory Signaling in Monocytes (2013) (56)
- A Multicenter, Randomized, Placebo‐Controlled Trial of Atorvastatin for the Primary Prevention of Cardiovascular Events in Patients With Rheumatoid Arthritis (2019) (56)
- Predicting sudden death in patients with mild to moderate chronic heart failure (2004) (56)
- Vitamin C and the risk of acute myocardial infarction. (2000) (56)
- Sex-Specific Thresholds of High-Sensitivity Troponin in Patients With Suspected Acute Coronary Syndrome (2019) (55)
- Outcome of Patients Receiving Thrombolytic Therapy While on Rivaroxaban for Nonvalvular Atrial Fibrillation (from Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation). (2017) (55)
- Sex-Specific Thresholds of High-Sensitivity Troponin in Patients With Suspected Acute Coronary Syndrome (2019) (55)
- Gallium-68 1,1,1-tris (5-methoxysalicylaldiminomethyl) ethane: a potential tracer for evaluation of regional myocardial blood flow. (1985) (55)
- Monocyte Functional Responsiveness After PSGL-1–Mediated Platelet Adhesion Is Dependent on Platelet Activation Status (2008) (55)
- Low-molecular-weight heparins in non-ST-segment elevation ischemia: the ESSENCE trial. Efficacy and Safety of Subcutaneous Enoxaparin versus intravenous unfractionated heparin, in non-Q-wave Coronary Events. (1998) (54)
- Chronicity of memory impairment in long-term out-of-hospital cardiac arrest survivors. (2000) (54)
- Management of acute coronary syndromes: an update (2004) (54)
- Mortality following non-ST elevation acute coronary syndrome: 4 years follow-up of the PRAIS UK Registry (Prospective Registry of Acute Ischaemic Syndromes in the UK). (2004) (54)
- Uncovering non-linear structure in human ECG recordings (2002) (54)
- Marked bradykinin-induced tissue plasminogen activator release in patients with heart failure maintained on long-term angiotensin-converting enzyme inhibitor therapy. (2002) (54)
- Early Risks of Death, Stroke/Systemic Embolism, and Major Bleeding in Patients With Newly Diagnosed Atrial Fibrillation: Results From the GARFIELD-AF Registry (2019) (53)
- The cost-effectiveness of an early interventional strategy in non-ST-elevation acute coronary syndrome based on the RITA 3 trial (2007) (53)
- Enoxaparin versus unfractionated heparin in patients treated with tirofiban, aspirin and an early conservative initial management strategy: results from the A phase of the A-to-Z trial. (2004) (53)
- Increased platelet responsiveness following coronary stenting. Heparin as a possible aetiological factor in stent thrombosis. (1998) (52)
- The temporal pattern of recovery of myocardial perfusion and metabolism delineated by positron emission tomography after coronary thrombolysis. (1987) (52)
- The value of routine non-invasive tests to predict clinical outcome in stable angina. (2003) (50)
- Different effects of calcium antagonists, nitrates, and beta-blockers on platelet function. Possible importance for the treatment of unstable angina. (1997) (50)
- Sharing Data from Cardiovascular Clinical Trials--A Proposal. (2016) (50)
- Use of concomitant aspirin in patients with atrial fibrillation: Findings from the ROCKET AF trial. (2016) (50)
- Bradykinin Contributes to the Systemic Hemodynamic Effects of Chronic Angiotensin-Converting Enzyme Inhibition in Patients With Heart Failure (2004) (50)
- Guideline-indicated treatments and diagnostics, GRACE risk score, and survival for non-ST elevation myocardial infarction (2018) (50)
- Effects of long-term, moderate-intensity oral anticoagulation in addition to aspirin in unstable angina. The Organization to Assess Strategies for Ischemic Syndromes (OASIS) Investigators. (2001) (50)
- Comparison of the anticoagulant intensities of fondaparinux and enoxaparin in the organization to assess strategies in acute ischemic syndromes (OASIS)‐5 trial (2010) (50)
- Abstract 148: Efficacy and Safety of Rivaroxaban Compared with Warfarin Among Elderly Patients with Nonvalvular Atrial Fibrillation in the ROCKET-AF Trial (2012) (49)
- Efficacy and safety of clopidogrel pretreatment before percutaneous coronary intervention with and without glycoprotein IIb/IIIa inhibitor use. (2008) (49)
- Bleeding, mortality, and antiplatelet therapy: results from the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial. (2011) (49)
- Role of Combination Antiplatelet and Anticoagulation Therapy in Diabetes Mellitus and Cardiovascular Disease (2020) (49)
- Inter-regional differences and outcome in unstable angina; analysis of the international ESSENCE trial. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-wave Coronary Events. (2000) (48)
- Redefining medical treatment in the management of unstable angina. (2011) (48)
- Performance of the GRACE Risk Score 2.0 Simplified Algorithm for Predicting 1-Year Death After Hospitalization for an Acute Coronary Syndrome in a Contemporary Multiracial Cohort. (2016) (48)
- Skeletal muscle contraction in healthy volunteers: assessment with Doppler tissue imaging. (1995) (48)
- Advances in the hospital management of patients following an out of hospital cardiac arrest (2012) (48)
- Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease (2017) (48)
- Effects of fondaparinux in patients with ST-segment elevation acute myocardial infarction not receiving reperfusion treatment. (2008) (48)
- The influence of body mass index on mortality and bleeding among patients with or at high-risk of atherothrombotic disease. (2008) (48)
- The incidence and clinical predictors of ACE-inhibitor induced dry cough by perindopril in 27,492 patients with vascular disease. (2014) (47)
- Early diagnosis of acute coronary syndrome (2017) (47)
- Reduced responsiveness to endothelin-1 in peripheral resistance vessels of patients with syndrome X. (1998) (47)
- Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study (2022) (47)
- Characterization of the functional significance of subcritical coronary stenoses with H(2)15O and positron-emission tomography. (1985) (47)
- End of Study Transition From Study Drug to Open-Label Vitamin K Antagonist Therapy: The ROCKET AF Experience (2013) (46)
- Comparison of enoxaparin versus unfractionated heparin in patients with unstable angina pectoris/non-ST-segment elevation acute myocardial infarction having subsequent percutaneous coronary intervention. (2002) (46)
- Rivaroxaban, an oral direct factor Xa inhibitor. (2008) (46)
- Use and outcomes of antiarrhythmic therapy in patients with atrial fibrillation receiving oral anticoagulation: results from the ROCKET AF trial. (2014) (44)
- The management and investigation of elderly patients with acute coronary syndromes without ST elevation: an evidence-based approach? Results of the Prospective Registry of Acute Ischaemic Syndromes in the United Kingdom (PRAIS-UK). (2005) (44)
- Influence of 23 coronary artery disease variants on recurrent myocardial infarction or cardiac death: the GRACE Genetics Study. (2013) (44)
- Effect of sustained low doses of diazepam on aggression and mortality in grouped male mice. (1969) (43)
- Impact of aspirin on presentation and hospital outcomes in patients with acute coronary syndromes (The Global Registry of Acute Coronary Events [GRACE]). (2002) (43)
- Increased aggression among grouped male mice fed chlordiazepoxide. (1970) (42)
- Network models for large cities: the European experience (2010) (42)
- Impact of chronic kidney disease on long-term ischemic and bleeding outcomes in medically managed patients with acute coronary syndromes: Insights from the TRILOGY ACS Trial (2016) (42)
- Platelet activation in patients with peripheral vascular disease: reproducibility and comparability of platelet markers. (2012) (42)
- British Cardiac Society Working Group on the definition of myocardial infarction (2004) (41)
- Applying novel methods to assess clinical outcomes: insights from the TRILOGY ACS trial. (2015) (41)
- Cardiac size, autonomic function, and 5-year follow-up of chronic heart failure patients with severe prolongation of ventricular activation. (2003) (41)
- Blood pressure control and stroke or bleeding risk in anticoagulated patients with atrial fibrillation: Results from the ROCKET AF Trial. (2016) (41)
- Personalising the decision for prolonged dual antiplatelet therapy: development, validation and potential impact of prognostic models for cardiovascular events and bleeding in myocardial infarction survivors (2017) (41)
- Registries and surveys in acute coronary syndrome. (2006) (40)
- Tissue-type plasminogen activator and plasminogen activator inhibitor activities as predictors of adverse events in unstable angina. (1994) (40)
- Fondaparinux compared to enoxaparin in patients with acute coronary syndromes without ST-segment elevation: outcomes and treatment effect across different levels of risk. (2009) (40)
- Impact of CYP2C19 Metabolizer Status on Patients With ACS Treated With Prasugrel Versus Clopidogrel. (2016) (40)
- Abstract 19281: Outcomes Following Cardioversion and Atrial Fibrillation Ablation in Patients Treated with Rivaroxaban and Warfarin in the ROCKET AF Trial (2012) (40)
- A global view of atherothrombosis: baseline characteristics in the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial. (2005) (40)
- Influence of rs5065 atrial natriuretic peptide gene variant on coronary artery disease. (2012) (39)
- Direct Oral Anticoagulants versus Warfarin in Patients with Atrial Fibrillation: Patient-Level Network Meta-Analyses of Randomized Clinical Trials with Interaction Testing by Age and Sex. (2022) (39)
- Challenges in comparing the non-vitamin K antagonist oral anticoagulants for atrial fibrillation-related stroke prevention (2018) (38)
- Native valve disease in patients with non-valvular atrial fibrillation on warfarin or rivaroxaban (2016) (38)
- Enhancing the efficacy of delivering reperfusion therapy: a European and North American experience with ST-segment elevation myocardial infarction networks. (2013) (38)
- Cardiac effects of sodium stibogluconate: myocardial, electrophysiological and biochemical studies. (1994) (38)
- Rivaroxaban, an oral direct factor Xa inhibitor (2008) (37)
- Effectiveness of primary percutaneous coronary intervention compared with that of thrombolytic therapy in elderly patients with acute myocardial infarction (2004) (37)
- Predictors of recurrent ischemic events and death in unstable coronary artery disease after treatment with combination antithrombotic therapy. (2000) (37)
- Routine Transesophageal Echocardiography for the Evaluation of Cerebral Emboli in Elderly Patients (2005) (37)
- Pathophysiology of myocardial reperfusion. (1987) (37)
- Marked impairment of protease-activated receptor type 1-mediated vasodilation and fibrinolysis in cigarette smokers: smoking, thrombin, and vascular responses in vivo. (2008) (37)
- Direct Vascular Effects of Protease-Activated Receptor Type 1 Agonism In Vivo in Humans (2006) (37)
- Rivaroxaban and Aspirin in Patients With Symptomatic Lower Extremity Peripheral Artery Disease: A Subanalysis of the COMPASS Randomized Clinical Trial. (2020) (37)
- Acute coronary syndromes: presentation—clinical spectrum and management (2000) (36)
- 2020 Update of the quality indicators for acute myocardial infarction: a position paper of the Association for Acute Cardiovascular Care: the study group for quality indicators from the ACVC and the NSTE-ACS guideline group. (2021) (36)
- Effect of DC shock on serum levels of total creatine kinase, MB-creatine kinase mass and troponin T. (1998) (36)
- Clopidogrel and Aspirin versus Aspirin Alone for the Prevention of Stroke in Patients with a History of Atrial Fibrillation: Subgroup Analysis of the CHARISMA Randomized Trial (2008) (35)
- Clopidogrel reduces platelet–leucocyte aggregation, monocyte activation and RANTES secretion in type 2 diabetes mellitus (2006) (35)
- The COMPASS Trial (2020) (35)
- Rivaroxaban Plus Aspirin in Patients With Vascular Disease and Renal Dysfunction: From the COMPASS Trial. (2019) (35)
- An international perspective on acute coronary syndrome care: insights from the Global Registry of Acute Coronary Events. (2004) (34)
- Stroke Outcomes in the Cardiovascular OutcoMes for People using Anticoagulation StrategieS (COMPASS) Trial (2018) (34)
- Predicting the risk of bleeding during dual antiplatelet therapy after acute coronary syndromes (2017) (34)
- Acute decline in renal function, inflammation, and cardiovascular risk after an acute coronary syndrome. (2009) (33)
- Clinical outcomes according to permanent discontinuation of clopidogrel or placebo in the CHARISMA trial. (2009) (33)
- Performance of the GRACE 2.0 score in patients with type 1 and type 2 myocardial infarction (2020) (33)
- Comparison of acute coronary syndrome in patients receiving versus not receiving chronic dialysis (from the Global Registry of Acute Coronary Events [GRACE] Registry). (2012) (33)
- Role of the endothelium in the vascular effects of the thrombin receptor (protease-activated receptor type 1) in humans. (2008) (33)
- Days Alive and Out of Hospital: Exploring a Patient-Centered, Pragmatic Outcome in a Clinical Trial of Patients With Acute Coronary Syndromes (2018) (33)
- Cardiovascular Risk Factors and In-hospital Mortality in Acute Coronary Syndromes: Insights From the Canadian Global Registry of Acute Coronary Events. (2015) (33)
- Effect of PON1 Q192R Genetic Polymorphism on Clopidogrel Efficacy and Cardiovascular Events in the Clopidogrel in the Unstable Angina to Prevent Recurrent Events Trial and the Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (2012) (33)
- Incidence and outcome of atrial fibrillation in stable symptomatic coronary disease (2006) (33)
- Hypercholesterolaemia and lipid lowering treatment do not affect the acute endogenous fibrinolytic capacity in vivo (2002) (32)
- Temporal trend of in-hospital major bleeding among patients with non ST-elevation acute coronary syndromes. (2010) (32)
- Dietary self-selection following subdiaphragmatic vagotomy in the white rat. (1976) (32)
- Persistent geographical disparities in the use of primary percutaneous coronary intervention in 120 European regions: exploring the variation. (2013) (32)
- Effect of Clopidogrel on the Rate and Functional Severity of Stroke Among High Vascular Risk Patients: A Prespecified Substudy of the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management and Avoidance (CHARISMA) Trial (2010) (32)
- An assessment of composite measures of hospital performance and associated mortality for patients with acute myocardial infarction. Analysis of individual hospital performance and outcome for the National Institute for Cardiovascular Outcomes Research (NICOR) (2013) (32)
- Rationale and design of the LosmApimod To Inhibit p38 MAP kinase as a TherapeUtic target and moDify outcomes after an acute coronary syndromE trial. (2015) (32)
- Determinants of use and outcomes of invasive coronary procedures in acute coronary syndromes: results from ENACT. (2003) (32)
- A European perspective on improving acute systems of care in STEMI: we know what to do, but how can we do it? (2008) (32)
- Management and 1‐Year Outcomes of Patients With Newly Diagnosed Atrial Fibrillation and Chronic Kidney Disease: Results From the Prospective GARFIELD‐AF Registry (2019) (32)
- The Role of Combination Antiplatelet and Anticoagulation Therapy in Diabetes and Cardiovascular Disease: Insights from the COMPASS Trial. (2020) (32)
- Measurement of platelet volume using a variety of different anticoagulant and antiplatelet mixtures (1996) (32)
- Coronary thrombolysis with facilitated absorption of intramuscularly injected tissue-type plasminogen activator. (1985) (32)
- Statistics on mortality following acute myocardial infarction in 842,897 Europeans. (2019) (31)
- Pregnancy Failure in Laboratory Mice after Multiple Short-term Exposure to Strange Males (1966) (31)
- Temporal trends and patterns of early clopidogrel use across the spectrum of acute coronary syndromes. (2009) (31)
- Efficacy and Safety of Rivaroxaban Versus Warfarin in Patients Taking Nondihydropyridine Calcium Channel Blockers for Atrial Fibrillation (from the ROCKET AF Trial). (2017) (31)
- Evolving quality standards for large-scale registries: the GARFIELD-AF experience (2016) (30)
- Regional variations of ultrasonic integrated backscatter in normal and myopathic left ventricles. A new multi-view approach. (1996) (30)
- Impact of availability and use of coronary interventions on the prescription of aspirin and lipid lowering treatment after acute coronary syndromes (2002) (30)
- Guía de práctica clínica de la ESC para el manejo del infarto agudo de miocardio en pacientes con elevación del segmento ST (2013) (30)
- Expert Consensus document on angiotensin converting enzyme inhibitors in cardiovascular disease (2004) (30)
- Randomized Controlled Trial of Dual Antiplatelet Therapy in Patients Undergoing Surgery for Critical Limb Ischemia (2010) (30)
- Timing of angiography with a routine invasive strategy and long-term outcomes in non-ST-segment elevation acute coronary syndrome: a collaborative analysis of individual patient data from the FRISC II (Fragmin and Fast Revascularization During Instability in Coronary Artery Disease), ICTUS (Invasive (2012) (29)
- Rivaroxaban Plus Aspirin Versus Aspirin Alone in Patients With Prior Percutaneous Coronary Intervention (COMPASS-PCI) (2020) (29)
- Acute systemic inflammation enhances endothelium-dependent tissue plasminogen activator release in men. (2003) (29)
- Hospitalizations in patients with atrial fibrillation: an analysis from ROCKET AF (2016) (29)
- Manufacture and acoustical characterisation of a high-frequency contrast agent for targeting applications. (2006) (29)
- The impact of beta-blockers on mortality in stable angina: a meta-analysis (2012) (29)
- Effects of a brief course of azithromycin on soluble cell adhesion molecules and markers of inflammation in survivors of an acute coronary syndrome: A double-blind, randomized, placebo-controlled study. (2004) (29)
- Effects of prepubertal habitation conditions on the reproductive physiology of the male house mouse. (1968) (28)
- Estimating individual lifetime benefit and bleeding risk of adding rivaroxaban to aspirin for patients with stable cardiovascular disease: results from the COMPASS trial. (2019) (28)
- Temporal changes in the management and outcome of Canadian diabetic patients hospitalized for non-ST-elevation acute coronary syndromes. (2011) (28)
- Brain natriuretic peptide is a potentially useful screening tool for the detection of cardiovascular disease in patients with rheumatoid arthritis (2005) (28)
- Regulation of peripheral vascular tone in patients with heart failure: contribution of angiotensin II (1998) (27)
- Comparison of utilization of statin therapy at hospital discharge and six-month outcomes in patients with an acute coronary syndrome and serum low-density lipoprotein>or=100 mg/dl versus<100 mg/dl. (2007) (27)
- Incidence and Outcomes of Gastrointestinal Hemorrhage in Patients With Atrial Fibrillation Treated With Rivaroxaban or Warfarin: Results From the ROCKET AF Trial (2012) (27)
- Health-Related Quality of Life and Mortality in Heart Failure (2021) (27)
- Concomitant proton-pump inhibitor use, platelet activity, and clinical outcomes in patients with acute coronary syndromes treated with prasugrel versus clopidogrel and managed without revascularization: insights from the Targeted Platelet Inhibition to Clarify the Optimal Strategy to Medically Manag (2015) (27)
- Risk factors and clinical outcomes in chronic coronary and peripheral artery disease: An analysis of the randomized, double-blind COMPASS trial (2020) (26)
- Major Bleeding in Patients With Coronary or Peripheral Artery Disease Treated With Rivaroxaban Plus Aspirin. (2019) (26)
- Prospective comparision of unstable angina versus non-Q wave myocardial infarction during antithrombotic therapy (1993) (26)
- Consistent substrate utilization despite reduced flow in hearts with maintained work. (1983) (26)
- Ascertainment, classification, and impact of neoplasm detection during prolonged treatment with dual antiplatelet therapy with prasugrel vs. clopidogrel following acute coronary syndrome. (2015) (26)
- Guidelines for the use of thrombolytic therapy (1995) (25)
- Reperfusion injury: laboratory phenomenon or clinical reality? (1992) (25)
- Characterisation and reproducibility of a human ex vivo model of thrombosis. (2010) (25)
- Impact of smoking status on platelet function and clinical outcomes with prasugrel vs. clopidogrel in patients with acute coronary syndromes managed without revascularization: Insights from the TRILOGY ACS trial. (2014) (25)
- Management patterns of non-ST segment elevation acute coronary syndromes in relation to prior coronary revascularization. (2010) (25)
- Mortality Benefit of Rivaroxaban Plus Aspirin in Patients With Chronic Coronary or Peripheral Artery Disease. (2021) (25)
- Whole blood sequencing reveals circulating microRNA associations with high-risk traits in non-ST-segment elevation acute coronary syndrome. (2017) (24)
- Bleeding and New Cancer Diagnosis in Patients with Atherosclerosis. (2019) (24)
- Determinants of clearance of tissue-type plasminogen activator (t-PA) from the circulation (1987) (24)
- Three-dimensional forward-viewing intravascular ultrasound imaging of human arteries in vitro. (2001) (24)
- Prognostic significance of presenting blood pressure in non-ST-segment elevation acute coronary syndrome in relation to prior history of hypertension. (2013) (24)
- COURAGE to change practice? Revascularisation in patients with stable coronary artery disease (2009) (24)
- Effect of PSI‐697, a Novel P‐Selectin Inhibitor, on Platelet–Monocyte Aggregate Formation in Humans (2013) (24)
- The Organization to Assess Strategies for Ischemic Syndromes (OASIS) registry in patients with unstable angina. (1999) (24)
- Effect of the small molecule plasminogen activator inhibitor‐1 (PAI‐1) inhibitor, PAI‐749, in clinical models of fibrinolysis (2010) (24)
- Functional interplay between platelet activation and endothelial dysfunction in patients with coronary heart disease (2006) (24)
- Treatment Consistency Across Levels of Baseline Renal Function With Rivaroxaban or Warfarin: A ROCKET AF (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation) Analysis. (2017) (24)
- Impact of Selection Bias on Estimation of Subsequent Event Risk (2017) (23)
- Doppler myocardial imaging vs. B-mode grey-scale imaging: a comparative in vitro and in vivo study into their relative efficacy in endocardial boundary detection. (1997) (23)
- Usefulness of the admission electrocardiogram to predict long-term outcomes after non-ST-elevation acute coronary syndrome (from the FRISC II, ICTUS, and RITA-3 [FIR] Trials). (2012) (23)
- Evaluation of the impact of the GRACE risk score on the management and outcome of patients hospitalised with non-ST elevation acute coronary syndrome in the UK: protocol of the UKGRIS cluster-randomised registry-based trial (2019) (23)
- Uric acid and other renal function parameters in patients with stable angina pectoris participating in the ACTION trial: impact of nifedipine GITS (gastro-intestinal therapeutic system) and relation to outcome (2007) (23)
- Anti-thrombotic options for secondary prevention in patients with chronic atherosclerotic vascular disease: what does COMPASS add? (2018) (23)
- Assessment of Quality Indicators for Acute Myocardial Infarction in the FAST-MI (French Registry of Acute ST-Elevation or Non–ST-Elevation Myocardial Infarction) Registries (2017) (23)
- Effect of Procedure and Coronary Lesion Characteristics on Clinical Outcomes Among Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention: Insights From the PIONEER AF-PCI Trial. (2018) (23)
- Total Center Percutaneous Coronary Intervention Volume and 30-Day Mortality: A Contemporary National Cohort Study of 427 467 Elective, Urgent, and Emergency Cases (2017) (23)
- Noninvasive, medical management for non-ST-elevation acute coronary syndromes. (2008) (23)
- High-Sensitivity Cardiac Troponin on Presentation to Rule Out Myocardial Infarction (2021) (23)
- Use of Dual Antiplatelet Therapy and Patient Outcomes in Those Undergoing Percutaneous Coronary Intervention: The ROCKET AF Trial. (2016) (23)
- Serum level of heart-type Fatty Acid-binding protein in patients with chronic renal failure. (2009) (22)
- A cluster randomized trial of objective risk assessment versus standard care for acute coronary syndromes: Rationale and design of the Australian GRACE Risk score Intervention Study (AGRIS). (2015) (22)
- Factors in pregnancy blocking: age and reproductive background of females: numbers of strange males. (1966) (22)
- Thrombolytic treatment for elderly patients. (1992) (22)
- The TETAMI Trial: The Safety and Efficacy of Subcutaneous Enoxaparin versus Intravenous Unfractionated Heparin and of Tirofiban versus Placebo in the Treatment of Acute Myocardial Infarction for Patients Not Thrombolyzed: Methods and Design (2000) (22)
- Identifying Acute Coronary Syndrome Patients Approaching End-of-Life (2012) (22)
- Bradykinin Receptor Antagonism and Endothelial Tissue Plasminogen Activator Release in Humans (2003) (22)
- Reperfusion strategies and outcomes of ST-segment elevation myocardial infarction patients in Canada: observations from the Global Registry of Acute Coronary Events (GRACE) and the Canadian Registry of Acute Coronary Events (CANRACE). (2012) (22)
- Coronary thrombolysis: pharmacological considerations with emphasis on tissue-type plasminogen activator (t-PA). (1984) (22)
- Heart rate variability and cardiac failure (1999) (22)
- Association of Chromosome 9p21 With Subsequent Coronary Heart Disease Events (2019) (21)
- Age-dependent inequalities in improvements in mortality occur early after acute myocardial infarction in 478,242 patients in the Myocardial Ischaemia National Audit Project (MINAP) registry. (2013) (21)
- Analysis of Outcomes in Ischemic vs Nonischemic Cardiomyopathy in Patients With Atrial Fibrillation: A Report From the GARFIELD-AF Registry. (2019) (21)
- Point-of-Care Warfarin Monitoring in the ROCKET AF Trial. (2016) (21)
- Scintigraphic detection of coronary artery thrombi in patients with acute myocardial infarction. (1984) (21)
- GRACE risk score: Sex-based validity of in-hospital mortality prediction in Canadian patients with acute coronary syndrome. (2017) (21)
- Long-term outcomes for women versus men with unstable angina/non-ST-segment elevation myocardial infarction managed medically without revascularization: insights from the TaRgeted platelet Inhibition to cLarify the Optimal strateGy to medicallY manage Acute Coronary Syndromes trial. (2015) (20)
- Global outcomes of ST-elevation myocardial infarction: comparisons of the Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment-Thrombolysis In Myocardial Infarction study 25 (ExTRACT-TIMI 25) registry and trial. (2007) (20)
- Use of proven therapies in non-ST-elevation acute coronary syndromes according to evidence-based risk stratification. (2007) (20)
- Association between smoking, outcomes, and early clopidogrel use in patients with acute coronary syndrome: insights from the Global Registry of Acute Coronary Events. (2010) (20)
- Abstract 152: Predictors of Intracranial Hemorrhage Among Anticoagulated Patients with Atrial Fibrillation: Insights from the Rivaroxaban Once-daily oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF) (2012) (20)
- r-hirudin in unstable angina pectoris. Rationale and preliminary data from the APT pilot study. (1995) (20)
- Use and timing of coronary angiography and associated in-hospital outcomes in Canadian non-ST-segment elevation myocardial infarction patients: insights from the Canadian Global Registry of Acute Coronary Events. (2013) (19)
- Promotion of proinflammatory interactions between platelets and monocytes by unfractionated heparin (2006) (19)
- Interventional versus conservative treatment in acute non-ST elevation coronary syndrome: time course of patient management and disease events over one year in the RITA 3 trial (2006) (19)
- Differential occurrence, profile, and impact of first recurrent cardiovascular events after an acute coronary syndrome (2017) (19)
- The FAST-MI 2005-2010-2015 registries in the light of the COMPASS trial: The COMPASS criteria applied to a post-MI population. (2019) (19)
- High-sensitivity C-reactive protein and clopidogrel treatment in patients at high risk of cardiovascular events: a substudy from the CHARISMA trial (2011) (19)
- High-Sensitivity Troponin I in Stable Patients with Atherosclerotic Disease in the TRA 2°P - TIMI 50 Trial. (2017) (19)
- Objective Risk Assessment vs Standard Care for Acute Coronary Syndromes: A Randomized Clinical Trial. (2020) (19)
- Cost-effectiveness of bivalirudin versus heparin plus glycoprotein IIb/IIIa inhibitor in the treatment of non-ST-segment elevation acute coronary syndromes. (2011) (19)
- Outcomes Associated With Oral Anticoagulants Plus Antiplatelets in Patients With Newly Diagnosed Atrial Fibrillation (2020) (18)
- 5-Year Outcome of an Interventional Strategy in Non-ST-Elevation Acute Coronary Syndrome: The British Heart Foundation RITA-3 Randomized Trial (2005) (18)
- An evaluation of composite indicators of hospital acute myocardial infarction care: a study of 136,392 patients from the Myocardial Ischaemia National Audit Project. (2013) (18)
- Patterns of use of heparins in ACS (2003) (18)
- An introduction to the Global Registry of Acute Coronary Events: GRACE (2000) (18)
- Prevalence of unsuspected and significant mitral and aortic regurgitation. (2008) (18)
- Clopidogrel: an updated and comprehensive review. (2007) (18)
- GRACE score predicts heart failure admission following acute coronary syndrome (2015) (18)
- USE AND OUTCOMES OF ANTIARRHYTHMIC THERAPY IN PATIENTS WITH ATRIAL FIBRILLATION RECEIVING ORAL ANTICOAGULATION: RESULTS FROM THE ROCKET AF TRIAL (2014) (18)
- Optimizing muscle synchronization after dynamic cardiomyoplasty. Two educational cases. (1995) (18)
- PARADIGM-HF--the experts' discussion. (2014) (17)
- Impact of Human Development Index on the profile and outcomes of patients with acute coronary syndrome (2014) (17)
- Implications of the Organization to Assess Strategies for Ischemic Syndromes-2 (OASIS-2) study and the results in the context of other trials. (1999) (17)
- Bleeding and related mortality with NOACs and VKAs in newly diagnosed atrial fibrillation: results from the GARFIELD-AF registry. (2021) (17)
- Spontaneous MI After Non-ST-Segment Elevation Acute Coronary Syndrome Managed Without Revascularization: The TRILOGY ACS Trial. (2016) (17)
- Comparative prognostic value of T-wave inversion and ST-segment depression on the admission electrocardiogram in non-ST-segment elevation acute coronary syndromes. (2013) (17)
- Ambulatory heart rate range predicts mode-specific mortality and hospitalisation in chronic heart failure (2015) (17)
- High sensitivity cardiac troponin and the under-diagnosis of myocardial infarction in women (2016) (17)
- Treating patients with acute coronary syndromes with aggressive antiplatelet therapy (from the Global Registry of Acute Coronary Events). (2005) (16)
- Alternative Calculations of Individual Patient Time in Therapeutic Range While Taking Warfarin: Results From the ROCKET AF Trial (2015) (16)
- High-Sensitivity Cardiac Troponin on Presentation to Rule Out Myocardial Infarction A Stepped-Wedge Cluster Randomized Controlled Trial (2021) (16)
- Secretory Phospholipase A2-IIA and Cardiovascular Disease A Mendelian Randomization Study (2017) (16)
- Predicting Outcome in Patients with Acute Coronary Syndrome: Evaluation of B-Type Natriuretic Peptide and the Global Registry of Acute Coronary Events (GRACE) Risk Score (2007) (16)
- GARFIELD-AF model for prediction of stroke and major bleeding in atrial fibrillation: a Danish nationwide validation study (2019) (16)
- Costs of an early intervention versus a conservative strategy in acute coronary syndrome. (2008) (16)
- Association between time of hospitalization with acute myocardial infarction and in-hospital mortality (2019) (16)
- Endogenous Tissue Plasminogen Activator Enhances Fibrinolysis and Limits Thrombus Formation in a Clinical Model of Thrombosis (2013) (15)
- Impact of an invasive strategy on 5 years outcome in men and women with non-ST-segment elevation acute coronary syndromes. (2014) (15)
- Frailty assessment and risk prediction by GRACE score in older patients with acute myocardial infarction (2020) (15)
- Response by Fox to Letter Regarding Article, "The COMPASS Trial: Net Clinical Benefit of Low-Dose Rivaroxaban Plus Aspirin as Compared With Aspirin in Patients With Chronic Vascular Disease". (2021) (15)
- Guidelines for the use of thrombolytic therapy. Haemostasis and Thrombosis Task Force of the British Committee for Standards in Haematology. (1995) (15)
- Utilization of catheterization and revascularization procedures in patients with non‐ST segment elevation acute coronary syndrome over the last decade (2005) (15)
- Selective Serotonin Reuptake Inhibitors and Bleeding Risk in Anticoagulated Patients With Atrial Fibrillation: An Analysis From the ROCKET AF Trial (2018) (15)
- Influence of differential vascular remodeling on the coronary vasomotor response. (2003) (15)
- Three-dimensional echocardiographic evaluation of left ventricular volume: comparison of Doppler myocardial imaging and standard gray-scale imaging with cineventriculography--an in vitro and in vivo study. (1998) (15)
- Cardiac troponins in chest pain (1999) (15)
- Clinical Characteristics, Management, and Outcomes of Acute Coronary Syndrome in Patients With Right Bundle Branch Block on Presentation. (2016) (14)
- Machine learning does not improve upon traditional regression in predicting outcomes in atrial fibrillation: an analysis of the ORBIT-AF and GARFIELD-AF registries. (2020) (14)
- Prognostic significance of low QRS voltage on the admission electrocardiogram in acute coronary syndromes. (2014) (14)
- GARFIELD-AF: a worldwide prospective registry of patients with atrial fibrillation at risk of stroke. (2020) (14)
- Optimal antithrombotic treatment during primary percutaneous coronary intervention? (2011) (14)
- Use of heparins in Non-ST-elevation acute coronary syndromes. (2007) (14)
- Subsequent Event Risk in Individuals With Established Coronary Heart Disease (2019) (14)
- Prognostic relevance of PCI-related myocardial infarction (2013) (14)
- Atherosclerosis stabilization with PCSK-9 inhibition: An evolving concept for cardiovascular prevention. (2015) (14)
- Efficacy and safety of rivaroxaban versus warfarin in patients from mainland China with nonvalvular atrial fibrillation: A subgroup analysis from the ROCKET AF trial. (2017) (14)
- Dual or single antiplatelet therapy with anticoagulation? (2013) (13)
- Antithrombotic Agents: Platelet Inhibitors, Anticoagulants, and Fibrinolytics (2009) (13)
- A randomized dose-ranging study of rt-PA in acute myocardial infarction. Effects on coronary patency and fibrinolytic parameters. (1990) (13)
- New artificial intelligence prediction model using serial prothrombin time international normalized ratio measurements in atrial fibrillation patients on vitamin K antagonists: GARFIELD-AF (2019) (13)
- New AI Prediction Model Using Serial PT-INR Measurements in AF Patients on VKAs: GARFIELD-AF. (2019) (13)
- Abstract 15544: Rivaroxaban Compared with Warfarin in Patients with Atrial Fibrillation and Diabetes: A Subgroup Analysis of the ROCKET AF Trial (2012) (13)
- Invasive assessment of the coronary circulation: intravascular ultrasound and Doppler. (2002) (13)
- 15 Investigation of IL-1 inhibition in patients presenting with non-ST elevation myocardial infarction acute coronary syndromes (the MRC ILA Heart Study) (2011) (13)
- Time trends in antithrombotic management of patients with atrial fibrillation treated with coronary stents: Results from TALENT‐AF (The internAtionaL stENT – Atrial Fibrillation study) multicenter registry (2018) (13)
- Heart-Type Fatty Acid-Binding Protein in the Early Diagnosis of Acute Myocardial Infarction: The potential for influencing patient management. (2010) (12)
- Noncentral Nervous System Systemic Embolism in Patients With Atrial Fibrillation: Results From ROCKET AF (Rivaroxaban Once Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation). (2017) (12)
- Circulating MicroRNA Profiling in Non-ST Elevated Coronary Artery Syndrome Highlights Genomic Associations with Serial Platelet Reactivity Measurements (2020) (12)
- Point-of-Care Warfarin Monitoring in the ROCKET AF Trial. (2016) (12)
- Efficacy and safety of rivaroxaban plus aspirin in women and men with chronic coronary or peripheral artery disease. (2020) (12)
- Pathophysiology of myocardial reperfusion. (1987) (12)
- Low molecular weight heparins in acute coronary syndromes. (1998) (12)
- Intramuscular administration of human tissue-type plasminogen activator in rabbits and dogs and its implications for coronary thrombolysis. (1987) (12)
- B1 Kinin Receptor Does Not Contribute to Vascular Tone or Tissue Plasminogen Activator Release in the Peripheral Circulation of Patients With Heart Failure (2005) (12)
- Use of clopidogrel post-coronary artery bypass surgery in canadian patients with acute coronary syndromes. (2011) (12)
- Prognostic value of dynamic electrocardiographic T wave changes in non-ST elevation acute coronary syndrome (2016) (12)
- Efficacy and safety of rivaroxaban compared with warfarin in patients with carotid artery disease and nonvalvular atrial fibrillation: Insights from the ROCKET AF trial (2016) (12)
- Laser Doppler anemometry measurements of the shear stresses on ultrasonic contrast agent microbubbles attached to agar. (2005) (12)
- Rationale, design, and baseline participant characteristics in the MRI and cognitive substudy of the cardiovascular outcomes for people using anticoagulation strategies trial (2018) (11)
- Double‐Dose Versus Standard‐Dose Clopidogrel According to Smoking Status Among Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention (2017) (11)
- Effect of implementing routine early invasive strategy on one-year mortality in patients with acute myocardial infarction. (2010) (11)
- Temporal Biomarker Profiling Reveals Longitudinal Changes in Risk of Death or Myocardial Infarction in Non-ST-Segment Elevation Acute Coronary Syndrome. (2017) (11)
- Have We Reached the Limit with Thrombolytic Therapy? (1999) (11)
- Thrombolysis: adjuvant therapy and the role of complement. (1990) (11)
- Unstable angina: the first 48 hours and later in-hospital management. (2001) (11)
- Metabolism of beta-methyl[1-11C]heptadecanoic acid in canine myocardium. (1987) (11)
- One-year outcomes after a strategy using enoxaparin vs. unfractionated heparin in patients undergoing fibrinolysis for ST-segment elevation myocardial infarction: 1-year results of the ExTRACT-TIMI 25 trial. (2010) (11)
- F-18-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques (2016) (11)
- Inducible nitric oxide synthase activity does not contribute to the maintenance of peripheral vascular tone in patients with heart failure. (2006) (11)
- Estratificación del riesgo en los síndromes coronarios agudos (2010) (11)
- Treatment of elderly patients (1993) (11)
- Use of clinical risk stratification in non-ST elevation acute coronary syndromes: an analysis from the CONCORDANCE registry (2018) (10)
- Plasma TAFI and soluble CD40 ligand do not predict reperfusion following thrombolysis for acute myocardial infarction. (2006) (10)
- Association Between Very Low Levels of High‐Density Lipoprotein Cholesterol and Long‐term Outcomes of Patients With Acute Coronary Syndrome Treated Without Revascularization: Insights From the TRILOGY ACS Trial (2016) (10)
- Comparative effectiveness of oral anticoagulants in everyday practice (2021) (10)
- Net clinical benefit of rivaroxaban compared with warfarin in atrial fibrillation: Results from ROCKET AF. (2018) (10)
- Characterisation of red and white thrombus by intravascular ultrasound using radiofrequency and videodensitometric data-based texture analysis. (1997) (10)
- Propranolol and Lidocaine Inhibit Neural Norepinephrine Release in Hearts With Increased Extracellular Potassium and Ischemia (1993) (10)
- Benzodiazepines and development of Swiss-Webster mice. (1977) (10)
- International comparison of acute myocardial infarction care and outcomes using quality indicators (2019) (10)
- Prospective comparison of unstable angina versus non-Q wave myocardial infarction during antithrombotic therapy. Antithrombotic Therapy in Acute Coronary Syndromes Research Group. (1993) (10)
- Association of International Normalized Ratio Stability and Bleeding Outcomes Among Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention: Insights From the PIONEER AF-PCI Trial (2019) (10)
- First Medical Contact-to-Device Time and Heart Failure Outcomes Among Patients Undergoing Primary Percutaneous Coronary Intervention (2018) (10)
- International longitudinal registry of patients with atrial fibrillation and treated with rivaroxaban: RIVaroxaban Evaluation in Real life setting (RIVER) (2019) (10)
- Outcomes with the use of glycoprotein IIb/IIIa inhibitors in non-ST-segment elevation acute coronary syndromes (2007) (10)
- Use of the GRACE score by cardiology nurse specialists in the emergency department (2010) (10)
- Oxazepam, prazepam, and aggression in mice. (1974) (10)
- Myocardial velocity gradient measured throughout the cardiac cycle in dilated cardiomyopathy hearts — A potential new parameter of systolic and diastolic myocardial function by Doppler myocardial imaging (1997) (10)
- Low-dose rivaroxaban and aspirin among patients with peripheral artery disease: a meta-analysis of the COMPASS and VOYAGER trials. (2021) (10)
- International longitudinal registry of patients with atrial fibrillation and treated with rivaroxaban: RIVaroxaban Evaluation in Real life setting (RIVER) (2019) (10)
- Bleeding events with antithrombotic therapy in patients with unstable angina or non-ST-segment elevation myocardial infarction; insights from a large clinical practice registry (GRACE). (2008) (10)
- Prior stroke and transient ischemic attack as risk factors for subsequent stroke in atrial fibrillation patients: A report from the GARFIELD-AF registry (2019) (10)
- Associations between model-predicted rivaroxaban exposure and patient characteristics and efficacy and safety outcomes in patients with non-valvular atrial fibrillation (2020) (9)
- Nice guidance on the investigation of chest pain (2010) (9)
- Radiation Exposure Levels in Family Members of Omani Patients with Thyrotoxicosis Treated with Radioiodine ( 131 I ) as Outpatients * (2009) (9)
- Previous and New Onset Atrial Fibrillation and Associated Outcomes in Acute Coronary Syndromes (from the Global Registry of Acute Coronary Events). (2018) (9)
- Why are outcomes different for registry patients enrolled prospectively and retrospectively? Insights from the global anticoagulant registry in the FIELD-Atrial Fibrillation (GARFIELD-AF) (2018) (9)
- Left ventricular function after extended hypothermic preservation of the heart is dependent on functional coronary capillarity. (1995) (9)
- Dual antiplatelet therapy in patients with diabetes and acute coronary syndromes managed without revascularization (2017) (9)
- Anomalous origin of the right coronary artery from the pulmonary artery in association with congenital aneurysm of the sinus of Valsalva: angiographic diagnosis of a rare association (1992) (9)
- Evolución hospitalaria asociada al empleo de fibrinolíticos y tienopiridinas en pacientes con infarto agudo de miocardio y elevación del segmento ST. The Global Registry of Acute Coronary Events (2009) (9)
- Time-Varying Effects of Prasugrel Versus Clopidogrel on the Long-Term Risks of Stroke After Acute Coronary Syndromes: Results From the TRILOGY ACS Trial (2016) (9)
- Total bleeding with rivaroxaban versus warfarin in patients with atrial fibrillation receiving antiplatelet therapy after percutaneous coronary intervention (2018) (9)
- Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry (2018) (8)
- Vascular B1 Kinin Receptors in Patients With Congestive Heart Failure (2008) (8)
- Latissimus dorsi muscle: assessment of stimulation after cardiomyoplasty with Doppler US tissue imaging. (1996) (8)
- Erratum to "Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation" (Eur Heart J (2002) 23, 1809-1840) (2003) (8)
- Preserved endothelial vasomotion and fibrinolytic function in patients with acute stent thrombosis or in-stent restenosis. (2003) (8)
- A Risk Assessment Tool Incorporating New Biomarkers for Cardiovascular Events in Acute Coronary Syndromes: The Organization to Assess Strategies in Ischemic Syndromes (OASIS) Risk Score. (2016) (8)
- Rivaroxaban Plus Aspirin in Obese and Overweight Patients With Vascular Disease in the COMPASS Trial. (2020) (8)
- Vasomotor and fibrinolytic responses to kinin receptor agonists in the atherosclerotic human lower limb (2012) (8)
- Stroke prevention with rivaroxaban in higher‐risk populations with atrial fibrillation (2015) (8)
- Prospective evaluation of a prostacyclin-sparing aspiring formulation and heparin/warfarin in aspirin users with unstable angina or non-Q wave myocardial infarction at rest (1994) (8)
- Safety and efficacy of non–vitamin K oral anticoagulant for atrial fibrillation patients after percutaneous coronary intervention: A bivariate analysis of the PIONEER AF‐PCI and RE‐DUAL PCI trial (2018) (7)
- Electrocardiographic Findings in Patients With Acute Coronary Syndrome Presenting With Out-of-Hospital Cardiac Arrest. (2018) (7)
- Low molecular weight heparin (enoxaparin) in the management of unstable angina: the ESSENCE study (1999) (7)
- Abstract 3294: Fondaparinux versus Control (Placebo or Unfractionated Heparin) as an Adjunct to Thrombolytic Therapy in Acute Myocardial Infarction: an OASIS 6 Substudy (2006) (7)
- Rivaroxaban for Prevention of Covert Brain Infarcts and Cognitive Decline (2020) (7)
- Characterisation of atherosclerotic plaque by spectral analysis of 30 MHz intravascular ultrasound radio frequency data (1996) (7)
- Comparing trials of glycoprotein IIb/IIIa receptor antagonists (1999) (7)
- High mortality rates in conservatively managed patients with acute coronary syndrome (2006) (7)
- 861-2 Enoxaparin versus unfractionated heparin in patients treated with tirofiban, aspirin, and an early conservation initial management strategy: Results from the A phase of the A to Z trial (2004) (7)
- Effects of benzodiazepines during gestation and infancy on Y-maze performance of mice. (1977) (7)
- Costs and cost effectiveness of low molecular weight heparins and platelet glycoprotein IIb/IIIa inhibitors (2012) (7)
- Public sensationalism and clinical trials: how to address the challenges of science? (2010) (7)
- Safety and Efficacy of Rivaroxaban in Patients With Cardiac Implantable Electronic Devices: Observations From the ROCKET AF Trial (2016) (7)
- Determinants of salvage of jeopardized myocardium after coronary thrombolysis. (1987) (6)
- Highlights of the 2009 scientific sessions of the European Society of Cardiology. (2009) (6)
- Temporal trends in all-cause mortality according to smoking status: Insights from the Global Registry of Acute Coronary Events. (2016) (6)
- Induction of implantation in the rat by cyclic nucleotides. (1977) (6)
- Why do clinicians withhold anticoagulation in patients with atrial fibrillation and CHA2DS2-VASc score ≥ 2? (2019) (6)
- Pre-Hospital Thrombolysis: Current Status and Future Prospects (1991) (6)
- Extensive aortic valve ring abscess formation: a rare complication of Q fever endocarditis. (1989) (6)
- Management and outcomes of patients presenting with STEMI by use of chronic oral anticoagulation: results from the GRACE registry (2013) (6)
- Mean myocardial velocity mapping in quantifying regional myocardial contractile reserve in patients with impaired left ventricular systolic function: Doppler myocardial imaging study. (2000) (6)
- VE-1902-A direct thrombin inhibitor with reversible covalent mechanism of action shows efficacy with reduced bleeding in rodent models of thrombosis. (2020) (6)
- Rivaroxaban and aspirin vs. aspirin alone in Asian compared with non-Asian patients with chronic coronary artery disease or peripheral arterial disease: the COMPASS trial. (2022) (6)
- Cost Implications of Anticoagulation Strategies After Percutaneous Coronary Intervention Among Patients With Atrial Fibrillation (A PIONEER-AF PCI Analysis). (2019) (6)
- Letter by Damman et al regarding articles, "Long-term cardiovascular mortality after procedure-related or spontaneous myocardial infarction in patients with non-ST-segment elevation acute coronary syndrome: a collaborative analysis of individual patient data from the FRISC II, ICTUS, and RITA-3 Tria (2012) (6)
- Hyperinsulinaemia in ischaemic heart disease: the importance of myocardial infarction and left ventricular function. (1994) (6)
- Incremental cost-effectiveness of early and long-term clopidogrel in patients undergoing percutaneous coronary infarction in the CURE trial: The PCI-CURE economic analysis (2003) (6)
- Risks associated with discontinuation of oral anticoagulation in newly diagnosed patients with atrial fibrillation: Results from the GARFIELD‐AF Registry (2021) (6)
- Prognostic significance of electrocardiographic-determined left ventricular hypertrophy and associated ST-segment depression in patients with non-ST-elevation acute coronary syndromes. (2011) (6)
- Long-Term Bleeding Risk Prediction with Dual Antiplatelet Therapy After Acute Coronary Syndromes Treated Without Revascularization (2020) (6)
- Benzodiazepines and reproduction of swiss-webster mice. (1976) (6)
- Abstract 13482: Ischemic Cardiac Outcomes in Patients with AF Treated with Vitamin K Antagonism or Factor Xa Inhibition: Results from the ROCKET AF Trial (2011) (6)
- Pulse pressure in acute coronary syndromes: Comparative prognostic significance with systolic blood pressure (2016) (6)
- Prospective use of glycoprotein IIb/IIIa receptor blockers in the emergency department setting. (1998) (6)
- Time‐trends and treatment gaps in the antithrombotic management of patients with atrial fibrillation after percutaneous coronary intervention: Insights from the CHUM AF‐STENT Registry (2019) (6)
- Influence of model-predicted rivaroxaban exposure and patient characteristics on efficacy and safety outcomes in patients with acute coronary syndrome (2019) (5)
- Validation of the myocardial-ischaemic-injury-index machine learning algorithm to guide the diagnosis of myocardial infarction in a heterogenous population: a prespecified exploratory analysis (2022) (5)
- Relation between previous angiotensin-converting enzyme inhibitor use and in-hospital outcomes in acute coronary syndromes. (2012) (5)
- Associations of osteopontin and NT-proBNP with circulating miRNA levels in acute coronary syndrome (2019) (5)
- Sex And Prognostic Significance of Self-Reported Frailty in Non-ST-Segment Elevation Acute Coronary Syndromes: Insights From the TRILOGY ACS Trial. (2019) (5)
- Impact of polyvascular disease on patients with atrial fibrillation: Insights from ROCKET AF (2018) (5)
- Thrombolysis and the general practitioner. 1. Practicable only under certain circumstances. (1990) (5)
- Health-related quality of life outcomes with prasugrel among medically managed non-ST-segment elevation acute coronary syndrome patients: Insights from the Targeted Platelet Inhibition to Clarify the Optimal Strategy to Medically Manage Acute Coronary Syndromes (TRILOGY ACS) trial. (2016) (5)
- Sunday, 26 August 2012 (2012) (5)
- Sex-specific evaluation and redevelopment of the GRACE score in non-ST-segment elevation acute coronary syndromes in populations from the UK and Switzerland: a multinational analysis with external cohort validation (2022) (5)
- 2020 Asian Pacific Society of Cardiology Consensus Recommendations on Antithrombotic Management for High-risk Chronic Coronary Syndrome (2021) (5)
- Comparative analysis of long-term mortality after thrombolytic therapy. (1991) (5)
- Patients selected for dual pathway inhibition in clinical practice have similar characteristics and outcomes to those included in the COMPASS randomized trial: The XATOA Registry. (2022) (5)
- A nationwide causal mediation analysis of survival following ST-elevation myocardial infarction (2019) (5)
- The 2020 ESC-ACVC quality indicators for the management of acute myocardial infarction applied to the FAST-MI registries. (2021) (5)
- Risk stratification of cardiovascular complications using CHA2DS2-VASc and CHADS2 scores in chronic atherosclerotic cardiovascular disease. (2021) (5)
- Ivabradine in stable coronary artery disease. (2014) (5)
- GARFIELD-AF risk score for mortality, stroke, and bleeding within 2 years in patients with atrial fibrillation (2021) (5)
- THROMBOLYTIC THERAPY IN ANTICOAGULATED PATIENTS: CASE SERIES FROM RIVAROXABAN VERSUS WARFARIN IN NONVALVULAR ATRIAL FIBRILLATION (ROCKET AF) (2017) (5)
- Dual Antiplatelet Therapy and Outcomes in Patients With Atrial Fibrillation and Acute Coronary Syndromes Managed Medically Without Revascularization: Insights From the TRILOGY ACS Trial (2016) (5)
- A robust prediction model for all forms of acute coronary syndromes: Estimating the risk of in-hospital death and myocardial infarction in the global registry of acute coronary events registry (2003) (4)
- Is myocardial ischemia really bad for you? (2014) (4)
- Abstract 15686: Polypharmacy and the Efficacy and Safety of Rivaroxaban versus Warfarin in the Prevention of Stroke: Results From the ROCKET AF Trial (2014) (4)
- Outcomes of patients with atrial fibrillation and significant valvular lesions: Comparison of the effects of rivaroxaban and warfarin in the ROCKET AF trial (2013) (4)
- Low-dose rivaroxaban plus aspirin in patients with polypharmacy and multimorbidity: an analysis from the COMPASS trial. (2021) (4)
- Effect of coronary flow on intracoronary alteplase: a prespecified analysis from a randomised trial (2021) (4)
- Treatment options in unstable angina: a clinical update. (1998) (4)
- A variant at chromosome 9 p 21 is associated with recurrent myocardial infarction and cardiac death after acute coronary syndrome (2010) (4)
- Inhibition of p38 MAP Kinase in Patients with ST-Elevation Myocardial Infarction - Findings from the LATITUDE TIMI 60 Trial. (2021) (4)
- Progress in cardiac positron emission tomography with emphasis on carbon-11 labeled palmitate and oxygen-15 labeled water (1987) (4)
- Associations between model-predicted rivaroxaban exposure and patient characteristics and efficacy and safety outcomes in the prevention of venous thromboembolism (2020) (4)
- Is clopidogrel plus aspirin more cost-effective than aspirin alone in high-risk patients with acute coronary syndromes? (2005) (4)
- Patient-Reported Satisfaction and Study Drug Discontinuation: Post-Hoc Analysis of Findings from ROCKET AF (2019) (4)
- Prospective evaluation of a prostacyclin-sparing aspirin formulation and heparin/warfarin in aspirin users with unstable angina or non-Q wave myocardial infarction at rest. The Antithrombotic Therapy in Acute Coronary Syndromes Research Group. (1994) (4)
- Abstract 14365: Rivaroxaban is Associated with a Reduced Risk of Thromboembolic events and Hemorrhagic Stroke in Patient with Heart Failure: Insights from ROCKET AF (2012) (4)
- 1040-71 Interhospital transfers are costly, cause delays and do not address the imbalance of access to revascularization: The case for more angiographic facilities? Results from the global registry of acute coronary events (2004) (4)
- Early discontinuation of prasugrel or clopidogrel in acute coronary syndromes: insights from the TRILOGY ACS trial (2018) (4)
- Report of the European Society of Cardiology Cardiovascular Round Table regulatory workshop update of the evaluation of new agents for the treatment of acute coronary syndrome: Executive summary (2019) (4)
- International comparisons of acute myocardial infarction (2014) (4)
- The safety of anistreplase from the placebo‐controlled aims study (anistreplase intervention mortality study) (1990) (3)
- Working Group on Thrombosis (2005) (3)
- Abstract 15879: Management of Major Bleeding Events in Patients Treated With Rivaroxaban Versus Warfarin: Results From the ROCKET AF Trial (2013) (3)
- 711-2 Recombinant-hirudin (CGP 39 393) Reduces the Incidence of Major Adverse Cardiac Events, Reported within the First 96 Hours Post-Angioplasty in Unstable Patients (Braunwald Classification) Pre-treated by Heparin (1995) (3)
- Digoxin and mortality in chronic heart failure. UK Heart Investigation. (1999) (3)
- 002 Rapid improvement in reperfusion strategy in europe: temporal trends in performance measures for reperfusion therapy in ST elevation myocardial infarction (2011) (3)
- Relationship of Platelet Reactivity With Bleeding Outcomes During Long‐Term Treatment With Dual Antiplatelet Therapy for Medically Managed Patients With Non‐ST‐Segment Elevation Acute Coronary Syndromes (2016) (3)
- One-Year Outcomes After Low-Dose Intracoronary Alteplase During Primary Percutaneous Coronary Intervention: The T-TIME Randomized Trial. (2020) (3)
- Monday, 27 August 2012 (2012) (3)
- Systemic atherosclerotic inflammation following acute myocardial infarction (2014) (3)
- IMPACT OF SMOKING STATUS ON CLINICAL OUTCOMES WITH PRASUGREL VERSUS CLOPIDOGREL IN PATIENTS WITH ACUTE CORONARY SYNDROMES MANAGED WITHOUT revascularization: INSIGHTS FROM THE TRILOGY ACS TRIAL (2013) (3)
- Rivaroxaban versus Warfarin in Patients with Atrial Fibrillation Enrolled in Latin America: Insights from ROCKET AF. (2021) (3)
- Termination of the CRESCENDO trial – Authors' reply (2010) (3)
- Impact of oral anticoagulation in patients with atrial fibrillation at very low thromboembolic risk (2019) (3)
- Anticoagulation in atrial fibrillation: the present and the future (2012) (3)
- Improved survival and reduced bleeding with low-molecular-weight heparin across all acute coronary syndrome subsets: findings from the global registry of acute coronary events (2002) (3)
- Altered learning by recipients of brain extracts from trained and retrained donors. (1974) (3)
- ROUTINE INVASIVE VERSUS SELECTIVE INVASIVE STRATEGY AND LONG-TERM OUTCOMES IN PATIENTS WITH REDUCED RENAL FUNCTION PRESENTING WITH NON-ST SEGMENT ELEVATION ACUTE CORONARY SYNDROME (2012) (3)
- Low molecular weight heparin (enoxaparin) in the management of unstable angina: the ESSENCE study. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q wave Coronary Events. (1999) (3)
- 1007-174 Clopidogrel regulates platelet, leukocyte, and endothelial interactions in type 2 diabetes mellitus (2004) (3)
- Liver-cell adenomas and peliosis hepatis in mice associated with oxazepam. (1974) (3)
- OBESITY PARADOX FOR STROKE IN PATIENTS WITH ATRIAL FIBRILLATION TREATED WITH RIVAROXABAN AND WARFARIN IN THE ROCKET AF TRIAL (2014) (3)
- Clopidogrel in coronary artery disease (2002) (3)
- Anti-thrombotic therapy in non-ST elevation acute coronary syndrome : article 1 (2007) (3)
- OUTCOMES OF TEMPORARY INTERRUPTIONS OF RIVAROXABAN OR WARFARIN IN PATIENTS WITH ATRIAL FIBRILLATION IN THE ROCKET AF TRIAL (2013) (2)
- In-hospital outcomes associated with fibrinolytic and thienopyridine use in patients with ST-segment elevation acute myocardial infarction. The global registry of acute coronary events. (2009) (2)
- COURAGE or FAME…? Who should have percutaneous coronary intervention in stable coronary artery disease? (2012) (2)
- NEW ONSET ATRIAL FIBRILLATION IN ACUTE CORONARY SYNDROME: FINDINGS FROM THE GRACE ECG SUBSTUDY (2016) (2)
- Natural Born Killers: The Assault Weapons Ban of the Crime Bill--Legitimate Exercise of Congressional Authority to Control Violent Crime or Infringement of a Constitutional Guarantee? (1994) (2)
- Cardiovascular consequences of discontinuing low-dose rivaroxaban in people with chronic coronary or peripheral artery disease (2021) (2)
- CLINICAL OUTCOME AND SENSITIVE TROPONIN I ASSAY IN PATIENTS WITH SUSPECTED ACUTE CORONARY SYNDROME (2010) (2)
- 1027-183 Functional interplay between endothelial dysfunction and platelet activation in patients with stable coronary heart disease (2004) (2)
- Long-Term Treatment with the Combination of Rivaroxaban and Aspirin in Patients with Chronic Coronary or Peripheral Artery Disease: Outcomes During the Open Label Extension of the COMPASS trial. (2022) (2)
- Dr. Fox responds (1992) (2)
- Coronary thrombolysis with human tissue-type plasminogen activator produced by recombinant DNA technology (1983) (2)
- Effect of prior clopidogrel use on outcomes in medically managed acute coronary syndrome patients (2016) (2)
- Specific antithrombins in the context of current treatment for acute coronary syndromes. (1999) (2)
- PROPRANOLOL IN THREATENED MYOCARDIAL INFARCTION (1979) (2)
- Acute coronary syndromes in 2010: Progress from trials to practice (2011) (2)
- Abstract 4585: Efficacy and Safety of Clopidogrel in Acute Coronary Syndrome Patients at High Risk of Bleeding: Data from the CURE Trial (2008) (2)
- High-sensitivity cardiac troponin on presentation to rule out myocardial infarction: a stepped-wedge cluster randomised controlled trial (2020) (2)
- High-Sensitivity Cardiac Troponin and the Diagnosis of Myocardial Infarction in Patients with Renal Impairment. (2022) (2)
- Quantitative laser Doppler anemometry measurements of the shear-stresses exerted on ultrasonic microbubbles attached to surfaces under physiological flow conditions (2004) (2)
- Oral anticoagulant use in cardiovascular disorders: a perspective on present and potential indications for rivaroxaban (2018) (2)
- Can statistical texture analysis of unprocessed intravascular ultrasound (IVUS) signal discriminate red and white thrombi acid plasma (1996) (2)
- Rationale , Design and Baseline Characteristics of Participants in the C ardiovascular O utco m es for P eople Using A nticoagulation S trategie s ( COMPASS ) Trial (2017) (2)
- Antithrombotic therapy in acute coronary syndromes: key notes from ESSENCE and TIMI 11B. (2001) (2)
- What’s new for ESC Congress 2013? (Amsterdam 30 August – 4 September 2013) (2013) (2)
- Current approaches to the management of stable angina (2011) (2)
- Long-term management of atherothrombosis. (2004) (2)
- CHARACTERISTICS AND OUTCOMES OF PATIENTS WITH ATRIAL FIBRILLATION AND SIGNIFICANT VALVULAR LESIONS: EXPERIENCE FROM THE ROCKET AF TRIAL (2013) (2)
- Associations between model-predicted rivaroxaban exposure and patient characteristics and efficacy and safety outcomes in the treatment of venous thromboembolism (2020) (2)
- Highlights of the 2008 Scientific Sessions of the European Society of Cardiology Munich, Germany, August 30 to September 3, 2008. (2008) (2)
- Outcomes of Patients Receiving Downstream Revascularization After Initial Medical Management for Non-ST-Segment Elevation Acute Coronary Syndromes (From the TRILOGY ACS Trial). (2018) (2)
- Comparison of Investigator-Reported vs Centrally Adjudicated Major Adverse Cardiac Events (2022) (2)
- Cardiovascular Disease Risk Prevention Across Europe (2007) (2)
- Invasive assessment of the coronary circulation (2002) (2)
- 1354The effect of non-recommended dosing of non-vitamin K antagonist oral anticoagulants (NOACs) on 1-year mortality in patients with newly diagnosed AF? Results from the GARFIELD-AF registry (2018) (2)
- GRACE RISK SCORE: SEX-BASED VALIDITY OF IN-HOSPITAL MORTALITY PREDICTION IN CANADIAN PATIENTS WITH ACUTE CORONARY SYNDROME (2016) (2)
- Do baseline characteristics and treatments account for geographical disparities in the outcomes of patients with newly diagnosed atrial fibrillation? The prospective GARFIELD-AF registry (2022) (2)
- Brain natriuretic peptide (BNP) is a potentially useful screening tool for the detection of cardiovascular disease in patients with rheumatoid arthritis (RA) (2005) (2)
- Clopidogrel: an updated and comprehensive review (2007) (2)
- Implementation of the NICE guidelines for the primary prevention of mortality from ventricular tachyarrhythmias: implications for UK electrophysiology centres; activity modelling from the UK-HEART study (2001) (2)
- Validity of Cardiac Markers as Diagnostic and Prognostic Indicators of Complications in Patients undergoing Percutaneous Coronary Intervention. (2010) (2)
- Clopidogrel in acute coronary heart disease. (2005) (2)
- 186 Ultrasonic characterisation of a newly developed targeted ultrasonic contrast agent (2003) (2)
- 'Where everything comes together!' European Society of Cardiology Congress 2014. (2014) (2)
- THE ASSOCIATION BETWEEN CONCOMITANT PROTON-PUMP INHIBITOR USE AND CLINICAL OUTCOMES IN PATIENTS WITH ACUTE CORONARY SYNDROMES TREATED WITH PRASUGREL VERSUS CLOPIDOGREL AND MANAGED WITHOUT REVASCULARIZATION: INSIGHTS FROM THE TRILOGY ACS STUDY (2013) (2)
- Can ultrasound texture analysis distinguish between red and white thrombi: A comparative study of intravascular videodensitometric and radiofrequency data (1996) (2)
- Abstract 3363: Anti-Ischemic and Antianginal Efficacy of Ivabradine, a Selective and Specific If Current Inhibitor, in Elderly Patients with Stable Angina (2006) (2)
- The benefit of an early invasive strategy in women versus men with non-ST-elevation acute coronary syndromes: A collaborative meta-analysis of randomized trials (2007) (2)
- Benzodiazepine-induced suppression of estrous cycles in C57BL/6J mice. (1975) (2)
- Non-invasive prognostic evaluation in stable angina combining echocardiography with clinical and exercise data in the total ischaemic burden European trial (TIBET). (2001) (1)
- Tuesday, 28 August 2012 (2012) (1)
- ADMISSION HYPERGLYCEMIA IMPROVES THE GRACE RISK SCORE FOR PREDICTION OF IN-HOSPITAL MORTALITY: INSIGHTS FROM THE EURO HEART SURVEY ACS III (2014) (1)
- Current drug therapies for the secondary prevention of MI (2008) (1)
- Republished paper: Nice guidance on the investigation of chest pain (2010) (1)
- What's new and what's different for ESC Congress 2013. (2013) (1)
- Safe use of platelet GP IIb/IIIa inhibitors. (1998) (1)
- Efficacy and safety of low-dose rivaroxaban on top of aspirin in patients with polypharmacy and multimorbidity: an analysis from the COMPASS trial (2020) (1)
- Differentiation between restrictive cardiomyopathy and constrictive pericarditis by the measurement of doppler myocardial imaging derived myocardial velocity gradient (1998) (1)
- P5708Balancing risk and benefit in patients with atrial fibrillation: the GARFIELD-AF risk score (2019) (1)
- P4565Rivaroxaban treatment strategies reduce not only the first bleeding event, but all (including multiple) bleeding events: A PIONEER Substudy (2017) (1)
- Pharmacotherapy for diabetes and stroke risk: Results from ROCKET AF (2021) (1)
- Characterisation of a newly developed ultrasonic contrast agent (2003) (1)
- 5 Implementation of a sensitive troponin I assay reduces death and recurrent myocardial infarction in patients with suspected acute coronary syndrome (2011) (1)
- Global reperfusion therapy in acute myocardial infarction - 1999 to 2004: We're getting better, but we have a long way to go. The Global Registry of Acute Coronary Events (2005) (1)
- Prognostic implications of prominent R wave in electrocardiographic leads V1 or V2 in patients with acute coronary syndrome. (2014) (1)
- Acute systemic inflammation enhances tissue plasminogen activator release in man (2002) (1)
- Rivaroxaban 2.5 mg Twice Daily Plus Aspirin Reduces Venous Thromboembolism in Patients With Chronic Atherosclerosis. (2022) (1)
- Effect of benzodiazepines on age of vaginal perforation and first estrus in mice. (1978) (1)
- Abstract 12776: Non-ST-segment Elevation Acute Coronary Syndromes Patients without Angiographically Detected Obstructive Coronary Artery Disease are Low-risk but Not No-risk: A Meta-analysis of 8 Trials of 37,101 Patients (2010) (1)
- 047 Clinical outcome and sensitive troponin I assay in patients with suspected acute coronary syndrome (2010) (1)
- P3590Rivaroxaban strategies improve the number of days patients remain out of the hospital and event free: A PIONEER substudy (2017) (1)
- Abstract 3855: Cost-Effectiveness of Clopidogrel + Aspirin vs. Aspirin Alone for Secondary Prevention of Cardiovascular Events: Results from the CHARISMA Trial (2006) (1)
- P6112Effect of procedure and lesion characteristics on bleeding and ischemic outcomes among atrial fibrillation patients undergoing percutaneous coronary intervention: results from the PIONEER AF-PCI trial (2017) (1)
- Assessment of transmural velocity gradients in hypertrophic hearts-A new diagnostic index for hypetrophic cardiomyopathy (1996) (1)
- Impact of NOAC and VKA on outcome of patients with newly diagnosed atrial fibrillation and diabetes: a report from the GARFIELD-AF registry (2021) (1)
- Abstract 3296: Effects of Fondaparinux in Patients with ST-Segment Elevation Acute Myocardial Infarction Non-Eligible for Reperfusion Treatment (2006) (1)
- Prevention of Bleeding in Atrial Fibrillation. (2017) (1)
- Independent Predictors of Mortality in Patients with Nonvalvular Atrial Fibrillation: Results from ROCKET AF (2012) (1)
- 903 The Targeted Platelet Inhibition to Clarify the Optimal Strategy to Medically Manage Acute Coronary Syndromes (TRILOGY ACS) Trial (2012) (1)
- THROMBOLYSIS "UPDATE" (1988) (1)
- Marked impairment of thrombin-mediated endothelial vasomotor and fibrinolytic function in cigarette smokers (2008) (1)
- External validation of the GRACE risk score 2.0 in the contemporary all‐comers GLOBAL LEADERS trial (2021) (1)
- Clinical Implications of CURE and PCI-CURE in Patients with the Acute Coronary Syndrome without Persistent ST-elevation (2002) (1)
- 3911Impact of CETP inhibition with evacetrapib in patients with diabetes mellitus: results from ACCELERATE (2017) (1)
- Prospective use of platelet glycoprotein IIb/IIIa receptor blockers in the emergency department setting. (1998) (1)
- Impaired endothelium-dependent vasomotion in patients with recent myocardial infarction and hyperhomocysteinemia (2003) (1)
- THE USE OF DUAL ANTIPLATELET THERAPY AND PATIENT OUTCOMES IN THOSE UNDERGOING PCI IN THE ROCKET AF TRIAL (2014) (1)
- Benefit of clopidogrel in patients undergoing percutaneous coronary intervention in the CURE trial receiving and not receiving an intracoronary stent (2003) (1)
- The role of moderate alcohol intake in first detected atrial fibrillation: The imperial college new AF study (2007) (1)
- CardioPulse: Anticoagulants reduce risk of death in atrialfibrillation patients by 38%. (2016) (1)
- P4569Rivaroxaban treatment strategies reduce costs associated with rehospitalizations due to bleeding and cardiovascular events: results from the PIONEER AF-PCI trial (2017) (1)
- 2005 IEEE Ultrasonics Symposium, Vols 1-4 (2005) (1)
- ACS scores: risky business? Reply (2009) (1)
- The effect of body mass index on clinical outcomes in patients with newly diagnosed atrial fibrillation in the GARFIELD-AF registry (2020) (1)
- Effect of PON 1 Q 192 R Genetic Polymorphism on Clopidogrel Efficacy and Cardiovascular Events in the CURE and ACTIVE Trials (2012) (1)
- Evaluation of vascular injury following percutaneous transluminal coronary angioplasty: a comparison of the accuracy of two‐ and three‐dimensional intracoronary ultrasound imaging (2003) (1)
- Síndromes coronarios agudos: fisiopatología, diagnóstico y estratificación del riesgo (2008) (1)
- Antiplatelet Therapy and Coronary Bypass Surgery: Risks and Benefits (2009) (1)
- P5355Impact of evacetrapib on glyvemic control: results from the accelerate trial (2017) (1)
- Novel Oral Anticoagulant Based Versus Vitamin K Antagonist Based Double Therapy Among Stented Patients With Atrial Fibrillation: Insights From the PIONEER AF-PCI Trial. (2019) (1)
- Focus on Risk Stratification and Outcomes in Patients with Acute Coronary Syndromes (2009) (1)
- Abstract 16840: Predictors of Hospitalization in Patients With Atrial Fibrillation: An Analysis From ROCKET AF (2014) (1)
- Implications of Lowering the Threshold of Plasma Troponin in the Diagnosis of Myocardial Infarction (2011) (1)
- Anatomical substrate for memory impairment after out-of-hospital cardiac arrest (2000) (1)
- Current drug therapies used in the secondary prevention of MI (2010) (1)
- Activated Protein C resistance in patients with unstable angina (1995) (0)
- Do women and men with unstable coronary artery disease benefit from an interventional strategy? Sex differences in the RITA-3 trial (2004) (0)
- Comparative Prognostic Value of T Wave Inversion and St Depression on the Admission ECG in Non-St Elevation Acute Coronary Syndromes (2013) (0)
- Stroke and bleed related deaths in newly diagnosed atrial fibrillation patients: insights from the GARFIELD-AF registry (2022) (0)
- Response by Piccini et al to Letters Regarding Article, "Polypharmacy and the Efficacy and Safety of Rivaroxaban Versus Warfarin in the Prevention of Stroke in Patients With Nonvalvular Atrial Fibrillation". (2016) (0)
- Abstract 14132: The Association of Volume of Patients Admitted with ST Elevation Myocardial Infarction, and the Proportion receiving Primary Percutaneous Coronary Intervention, with Time Delays and Mortality: The Myocardial Ischaemia National Audit Project (MINAP) 2004-7. (2010) (0)
- Reply to letter: "Randomized controlled trial of dual antiplatelet therapy in patients undergoing surgery for critical limb ischemia". (2014) (0)
- Unfractionated heparin increases platelet-monocyte binding in vitro and in patients undergoing percutaneous coronary intervention (2003) (0)
- Abstract 17137: Renal Dysfunction is a Potent Predictor of Stroke and Systemic Embolism Among Individuals with Atrial Fibrillation: Results from the ROCKET AF Trial (2011) (0)
- Abstract 078: Implications of Patient-Reported Treatment Satisfaction for Discontinuation of Rivaroxaban versus Warfarin in ROCKET-AF (2017) (0)
- Direct Oral Anticoagulants Versus Warfarin Across the Spectrum of Kidney Function: Patient-Level Network Meta-Analyses From COMBINE AF. (2023) (0)
- Composite quality scores for care of acute myocardial infarction patients at discharge from hospital: a study of 136,392 patients from the Myocardial Ischaemia National Audit Project (MINAP) (2013) (0)
- experience Network models for large cities : the European (2009) (0)
- Clinical Characteristics and Outcomes of Patients with Peripheral Artery Disease in the Prospective XATOA Registry Study (2022) (0)
- A Direct Relationship between Acute Heart Failure and Parasympathetic Activity following Myocardial Infarction (1994) (0)
- Stable angina: current guidelines and advances in management (2013) (0)
- IMPACT OF PRIOR CLOPIDOGREL USE ON ISCHEMIC OUTCOMES AMONG MEDICALLY MANAGED PATIENTS WITH NON-ST-ELEVATION ACUTE CORONARY SYNDROMES: RESULTS FROM THE TRILOGY ACS TRIAL (2014) (0)
- Abstract 17226: Latin American Patients With Atrial Fibrillation Have a Higher Risk Profile but Similar Response With Rivaroxaban versus Warfarin: A ROCKET AF Substudy (2017) (0)
- Limited impact of treatment with statins on early outcomes in unselected patients with acute coronary events. Insights from the global registry of acute coronary events (GRACE) (2003) (0)
- Randomized Trial of Low Molecular Weight Heparin (Enoxaparin) Versus Unfractionated Heparin for Unstable Coronary Artery Disease One-Year Results of the ESSENCE Study Enoxaparin in Non–Q (2016) (0)
- Clinical Research Use of Clopidogrel Post-Coronary Artery Bypass Surgery in Canadian Patients With Acute Coronary Syndromes (2011) (0)
- Edinburgh Research Explorer A variant at chromosome 9p21 is associated with recurrent myocardial infarction and cardiac death after acute coronary syndrome (2017) (0)
- GRACE: Long-Term Outcomes in NSTEMI and UA No Better than in STEMI (2010) (0)
- Secondary prevention of MI: current approaches to treatment (2013) (0)
- Domiciliary thrombolysis by general practitioners. (1992) (0)
- Haemostatic markers in unstable angina: a case control study (1996) (0)
- Circulating MicroRNA Profiling in Non-ST Elevated Coronary Artery Syndrome Highlights Genomic Associations with Serial Platelet Reactivity Measurements (2020) (0)
- RELATIONSHIP BETWEEN BLEEDING AND MORTALITY IN PATIENTS ON DUAL ANTIPLATELET THERAPY VS ASPIRIN ALONE: RESULTS FROM THE CHARISMA TRIAL (2011) (0)
- Cisco: lecciones aprendidas sobre "branding" (2004) (0)
- Reperfusion arrhythmias. (1993) (0)
- 025 COMPOSITE QUALITY SCORES FOR CARE OF ACUTE MYOCARDIAL INFARCTION PATIENTS AT DISCHARGE FROM HOSPITAL: A STUDY OF 136 392 PATIENTS FROM THE MYOCARDIAL ISCHAEMIA NATIONAL AUDIT PROJECT (MINAP) (2013) (0)
- Missed opportunities across the pathway of care and mortality for eligible patients with ST-elevation myocardial infarction (2013) (0)
- Vitamin C and the risk of acute myocardial infarction 1–3 (2000) (0)
- Long-term outcomes for women vs. men with unstable angina/non-ST-segment elevation myocardial infarction managed medically without revascularization: Insights from the TRILOGY ACS trial (2015) (0)
- Reply: Do the 10-Year Mortality Outcomes of RITA-3 Inform Contemporary Clinical Practice? (2016) (0)
- Association of body mass index with outcomes in patients with newly diagnosed atrial fibrillation: GARFIELD-AF (2022) (0)
- Intravenous heparin, low-molecular-weight heparins, and thrombin antagonists (2011) (0)
- CONSISTENT LOW-DENSITY LIPOPROTEIN CHOLESTEROL LOWERING EFFICACY OF ALIROCUMAB IN HIGH AND VERY HIGH CARDIOVASCULAR RISK PATIENTS WITH LOW-DENSITY LIPOPROTEIN CHOLESTEROL >100/70 MG/DL AT BASELINE (2017) (0)
- 1129-212 Endothelial, coagulation, and platelet function in atrial fibrillation: Effect of direct current cardioversion (2004) (0)
- Abstract 12712: Gender Disparities in the Management and In-Hospital Outcomes Acute Myocardial Infarction: Temporal Changes Between 2006 and 2008. Insights from the Euro Heart Survey ACS III registry (2011) (0)
- Assessment of Skeletal Muscle Ventricle Function Using Tissue Velocity Imaging (1997) (0)
- Poor Outcomes in Chronic Kidney Disease (CKD) With and Without Reperfusion After ST Elevation/Left Bundle Branch Block (STE/LBBB) (2007) (0)
- Abstract 3805: The Use of COX-2 Inhibitors and the Risk of Myocardial Infarction in the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) Trial (2006) (0)
- PROGNOSTIC VALUE OF T-WAVE INVERSION ON THE PRESENTING VERSUS FOLLOW-UP ECG IN NON-ST ELEVATION ACUTE CORONARY SYNDROMES (2015) (0)
- Abstract 13270: Relationship of Longitudinal Measurements of Biomarkers of Hemodynamic Stress, Systemic Inflammation, and Platelet Reactivity with Ischemic Outcomes in Non-ST-Elevation Acute Coronary Syndrome Patients Managed Without Revascularization (2014) (0)
- Sex-Speci fi c Thresholds of High-Sensitivity Troponin in Patients With Suspected Acute Coronary Syndrome (2019) (0)
- Abstract 13208: Time-Dependent Interactions of Prasugrel vs Clopidogrel on the Long-Term Risks of Stroke after Acute Coronary Syndromes: Results from the TRILOGY ACS Trial (2014) (0)
- PERFORMANCE MEASURES IN ST SEGMENT ELEVATION MYOCARDIAL INFARCTION: 2 YEARS TEMPORAL CHANGES AND ROOM FOR IMPROVEMENT. INSIGHTS FROM THE EURO HEART SURVEY ACS III REGISTRY (2011) (0)
- Abstract 12958: Betablocker Use in Patients with Chronic Pulmonary Disease During Acute Phase of Myocardial Infarction. Insights from Euro Heart Survey Acute Coronary Syndromes III (2012) (0)
- Abstract 15339: Implications of Lowering the Threshold of Plasma Troponin in the Diagnosis of Myocardial Infarction (2011) (0)
- Bedside predictors of progressive heart failure: 5-year follow-up of the UK-HEART study (2001) (0)
- The BEAUTIFUL study: Baseline characteristics of included patients (2007) (0)
- Explorer Serum level of heart-type Fatty Acid-binding protein in patients with chronic renal failure (2018) (0)
- Enoxaparin treatment in unstable coronary artery disease: international cost savings. (2002) (0)
- GARFIELD-AF: risk profiles, treatment patterns and 2-year outcomes in patients with atrial fibrillation in Germany, Austria and Switzerland (DACH) compared to 32 countries in other regions worldwide (2022) (0)
- ¿Qué hay de nuevo para el congreso ESC 2013? (Ámsterdam 30 agosto-4 septiembre de 2013) (2013) (0)
- University of Birmingham Safety and efficacy of non–vitamin K oral anticoagulant for atrial fibrillation patients after percutaneous coronary intervention: (2018) (0)
- The PlA2 polymorphism in human platelet membrane GPIIIa is associated with increased fibrinogen binding to stimulated platelets (1997) (0)
- Influence of rs5065 Atrial Natriuretic Peptide Gene Variant on Coronary Artery Disease (2012) (0)
- PCV100 Resource Use in Patients with Acute Coronary Syndrome - an Observational Study Across Secondary and Primary Care in a UK Population (2011) (0)
- Mortality, autonomic and myocardial abnormalities in chronic heart failure patients with markedly prolonged ventricular activation (2002) (0)
- 026 TRENDS IN IN-HOSPITAL TREATMENTS, INCLUDING REVASCULARISATION, FOLLOWING ACUTE MYOCARDIAL INFARCTION, 2003–2010: A MULTI-LEVEL AND RELATIVE SURVIVAL ANALYSIS FOR THE NATIONAL INSTITUTE FOR CARDIOVASCULAR OUTCOMES RESEARCH (NICOR) (2013) (0)
- Diminished aggression by recipients of brain extracts from trained aggressor mice. (1974) (0)
- Risk of new onset atrial fibrillation following an acute coronary syndrome: data from the GRACE registry (2016) (0)
- What's new for ESC congress 2013? (Amsterdam 30th august - 4th September 2013). (2013) (0)
- Abciximab with low-dose heparin prevented complications following percutaneous coronary revascularization without increased bleeding risk. (1997) (0)
- Antiplatelet Therapies: Aspirin, Thienopyridines, and Glycoprotein IIb/IIIa Receptor Inhibitors (2009) (0)
- ¿Qué novedades trae el Congreso de la Sociedad Europea de Cardiología 2013? (Ámsterdam; Agosto 30 – Septiembre 4, 2013) (2013) (0)
- Implications of statin use on the health burden and economic costs of acute coronary syndromes without ST elevation Prospective registry of acute ischaemic syndromes in the United Kingdom (2000) (0)
- Tumor necrosis factor-a impairs endothelium-dependent vasodilatation and stimulates local tissue plasminogen activator release in humans: Diverse vascular actions of a pleiotropic cytokine (2003) (0)
- Improved prediction of cardiac, limb and bleeding events in patients with coronary and peripheral arterial disease using machine learning models and artificial intelligence (2020) (0)
- P4616Frailty assessment and risk prediction by GRACE score in older patients with acute myocardial infarction (2018) (0)
- Fondaparinux in Patients with Impaired Renal Function: The Right Choice? (2008) (0)
- Differential effects of captopril and hydralazine on autonomic function in cardiac failure (1996) (0)
- Evaluación del riesgo ambiental con HERA: Retos y soluciones (2002) (0)
- [PP.35.22]: LIFELONG BENEFITS OF ACE INHIBITORS ON CARDIOVASCULAR EVENTS AND MORTALITY IN HYPERTENSIVE PATIENTS (2015) (0)
- Increased CD40 ligand, C-reactive protein, and platelet-monocyte binding in patients with type 1 diabetes mellitus (2003) (0)
- Cuáles son las novedades del Congreso de la Sociedad Europea de Cardiología (ESC) 2013 (2013) (0)
- Universal Clinician Device for improving risk prediction and management of patients with atrial fibrillation: an assumed benefit analysis (2022) (0)
- Edinburgh Research Explorer Sex-Specific Thresholds of High-Sensitivity Troponin in Patients With Suspected Acute Coronary Syndrome (2019) (0)
- Abstract 19024: Regulation of Platelet Reactivity Identified Through MicroRNA Profiling in Acute Coronary Syndrome (2016) (0)
- P847Performance of the GRACE score in patients with type 1 and type 2 myocardial infarction (2019) (0)
- ACE inhibition and tissue plasminogen activator release in patients with heart failure (2002) (0)
- Abstract 3770: Stroke Risk Score in Patients with Acute Coronary Syndromes. The Global Registry of Acute Coronary Events (2007) (0)
- UPTAKE OF THE 2016 CCS AF GUIDELINES FOR PATIENTS WITH ATRIAL FIBRILLATION UNDERGOING PERCUTANEOUS CORONARY INTERVENTION (2018) (0)
- updateof acute coronary syndromes: an (2006) (0)
- Patient characteristics and clinical events from GRACE and SYNERGY: Differences persist in utilization of standard therapies in clinical practice (2005) (0)
- Health-related quality of life outcomes with prasugrel among medically man- aged non-ST-segment elevation acute coronary syndrome patients: Insights from the TRILOGY ACS trial (2016) (0)
- Routine addition of heparin to aspirin in acute myocardial infarction provides only modest benefit. (1997) (0)
- Eptifibatide did not significantly reduce the rate of adverse events in patients undergoing percutaneous coronary revascularization. (1997) (0)
- Comparative effectiveness of primary percutaneous coronary intervention versus fibrinolytic therapy for ST-elevation myocardial infarction by time to treatment. A national cohort study (2015) (0)
- Expression of platelet P-selectin varies with anticoagulant (1995) (0)
- Abstract 14086: Investigation of Inflammatory Markers and Cardiac Events Following Discontinuation of Interleukin-1 Receptor Antagonist in NSTE-ACS Patients (2015) (0)
- Beneficio inmediato y a largo plazo del clopidogrel en pacientes con síndrome coronario agudo (2004) (0)
- Abstract 13144: MicroRNA Sequencing Highlights Regulatory Networks Upstream of Osteopontin and B-type Natriuretic Peptide in Acute Coronary Sydrome (2016) (0)
- Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation the Investigators* (0)
- Prognostic Implications of Prominent R Waves in V1 Or V2 in Patients With Acute Coronary Syndrome (2013) (0)
- Anti-thrombotic therapy in non-ST elevation acute coronary syndrome KAA Fox (2017) (0)
- NUMBER OF TRADITIONAL CARDIOVASCULAR RISK FACTORS AND MANAGEMENT AND OUTCOME IN ACUTE CORONARY SYNDROME (2014) (0)
- Influence of guidelines and results from major clinical trials on medical practice: Findings from the global registry of acute coronary events (GRACE) (2003) (0)
- The GRACE (Global Registration of Acute Coronary Events) score predicts heart failure readmission (2013) (0)
- TCT CONNECT-16 Implications of Impaired Coronary Flow on the Effects of Intracoronary Alteplase During Primary Percutaneous Coronary Intervention (2020) (0)
- Management of acute coronary syndromes. (2005) (0)
- Effect of Procedure and Coronary Lesion Characteristics on Clinical Outcomes Among Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention AF-PCI (2018) (0)
- Coronary Artery Disease ealth-Related Quality of Life After nterventional or Conservative Strategy n Patients With Unstable Angina or on – ST-Segment Elevation Myocardial Infarction ne-Year Results of the Third Randomized ntervention Trial of Unstable Angina ( RITA-3 ) (2016) (0)
- Expert Answers to Three Key Questions (1996) (0)
- Chapter 40 Systems of care for patients with acute coronary syndrome (2010) (0)
- Reply: Survival Differences in Clinical Trials With Long-Term Follow-up. (2016) (0)
- The Impact of Chronic Liver Diseases on the Level of Heart-Type Fatty Acid-Binding Protein (H-FABP) Concentrations. (2009) (0)
- High pressure versus larger calibre to achieve an optimal balloon size in coronary angioplasty: interim results of an in vitro intravascular ultrasound study (1998) (0)
- ROCKET-AF: Rivaroxaban vs Warfarin in Patients with Moderate Renal Insufficiency (2011) (0)
- EFFECT OF ACE INHIBITORS AND ANGIOTENSIN II RECEPTOR BLOCKERS ON ALL-CAUSE MORTALITY IN HYPERTENSION TRIALS: 3A.03 (2011) (0)
- What's new for ESC Congress 2013? (Amsterdam 30th August-4th September 2013). (2013) (0)
- What’s new for ESC Congress 2013? (Amsterdam 30th August - 4th-09-2013) (2013) (0)
- Abstract 16711: Timing of Angiography in Non-ST-elevation Acute Coronary Syndromes and the Effect on Cardiovascular Mortality and Myocardial Infarction. (2010) (0)
- The authors’ reply: (1989) (0)
- Frailty is associated with worse outcomes in acute coronary syndromes: outcomes in TRILOGY (2013) (0)
- Troponin Trumps Common Sense (2006) (0)
- Hyperglycemia increases Hospital Mortality in Patients with Acute Coronary Syndromes: Results from the Global Registry of Acute Coronary Events (2004) (0)
- SIGNIFY: Treatment with Ivabradine Does Not Improve Outcomes and May Increase Risk in Patients with Angina (2014) (0)
- P3622Timing of trial stoppage for non-inferiority trials and interpretation: lessons from ROCKET AF (2017) (0)
- Why do clinicians prescribe oral anticoagulation in patients with atrial fibrillation despite a low CHA2DS2-VASc score? (2019) (0)
- CHA2DS2-VASc and CHADS2 scores for risk stratification of major adverse cardiovascular events in the COMPASS trial (2020) (0)
- Abstract 3297: The Impact of Renal Dysfunction on Bleeding and Outcome in ST-Elevation MI: Results of the ExTRACT-TIMI25 Study (2006) (0)
- Characteristics and outcome in patients with chronic HEART failure and preserved ejection fraction in the UK-HEART study (2002) (0)
- The effect of interleukin-1 receptor antagonist therapy on markers of inflammation in non-ST elevationacutecoronarysyndromes:theMRC-ILA (2014) (0)
- Hypertension Later in Life (2004) (0)
- Commentaries on last month's Controversy articles on reperfusion arrhythmias (1993) (0)
- Parametric imaging with intravascular ultrasound: colour-coded identification of plaque morphology (1998) (0)
- Abstract 3081: CHARISMA (long-term dual anti-platelet therapy): The Impact of Risk Status, Prior History, and Proximity to Recent Cardiovascular Events (2006) (0)
- 125 Performance and evolution of the primary PCI service in England and Wales from 2004 to 2007 (2010) (0)
- St Segment Changes and Recurrent Chest Pain as Predictors of Short term Cardiac Events in Unstable Angina (1994) (0)
- Antithrombotic treatment strategies in patients with established coronary atherosclerotic disease: 2022 joint clinical consensus statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI), Association for Acute CardioVascular Care (ACVC) and European Association of Pr (2023) (0)
- Risk stratification in acute coronary syndromes. (2010) (0)
- Incident atrial fibrillation and new heart failure: The chicken or the egg? Insights from the imperial college new AF study (2007) (0)
- Comparing rivaroxaban and apixaban in GARFIELD-AF according to ROCKET AF and ARISTOTLE trial selection criteria (2021) (0)
- EFFECTS OF PREPUBERTAL HABITATION CONDITIONS ON THE REPRODUCTIVE PHYSIOLOGY OF THE MALE HOUSE MOUSE (2008) (0)
- Impaired recovery of myocardial metabolism detected by positron tomography despite restoration of flow by coronary thrombolysis (1982) (0)
- Antithrombotic Therapies for Patients with ST Segment Elevation Myocardial Infarction (2010) (0)
- Management of unstable angina. (2000) (0)
- Metabolie Fate of Radiolabeled Palmitate in Ischemie Canine Myocardium: Implications for Positron Emission Tomography (2006) (0)
- Explorer Cardiac markers in the early diagnosis and management of patients with acute coronary syndrome (2017) (0)
- Circulation, Supplement I (1995) (0)
- Is primary angioplasty better than thrombolytic therapy in elderly patients with acute myocardial infarction? An insight from the Global Registry of Acute Coronary Events (GRACE) (2002) (0)
- The impact of underlying risk and gender on the benefit of early intervention in non-ST elevation acute coronary syndrome patients: findings from the RITA-3 trial (2005) (0)
- 119 Prognostic Significance of Presenting Blood Pressure in Non-ST Elevation Acute Coronary Syndromes in Relation to Prior History of Hypertension (2012) (0)
- PERFORMANCE MEASURES FOR IN-HOSPITAL MANAGEMENT OF ACUTE CORONARY SYNDROMES IN EUROPE (2010) (0)
- P4800Why do clinicians prescribe oral anticoagulation in patients with atrial fibrillation despite a low CHA2DS2-VASc score? (2018) (0)
- 023 Risk Stratification Using CHA2DS2-VASc and CHADS2 Scores in Patients With Chronic Atherosclerotic Cardiovascular Disease Receiving Aspirin With or Without Rivaroxaban: An Analysis of the COMPASS Trial (2020) (0)
- Health related quality of life after an interventional V conservative treatment strategy for unstable angina or non-ST elevation myocardial infarction: Interim results of the RITA-3 trial (2004) (0)
- P43. Platelet activation in unstable angina: a case control study (1996) (0)
- trial acute coronary syndrome based on the RITA 3 interventional strategy in non-ST-elevation The cost-effectiveness of an early (2008) (0)
- Impact of Rivaroxaban Alone or in Combination With Aspirin Versus Aspirin in Preventing Graft Occlusion in Patients With CABG Surgery: The COMPASS CABG Analysis (2018) (0)
- TREATMENT FOR ELDERLY PATIENTS (1993) (0)
- Prognosis of heart failure in the general population results from the London heart failure studies (2002) (0)
- Monocyte functional responsiveness following PSGL-1 mediated platelet adhesion is dependent upon platelet activation status (2008) (0)
- Clinical outcomes of patients with newly diagnosed atrial fibrillation who refused anticoagulation: findings from the global GARFIELD-AF registry (2020) (0)
- The RITA 3 trial. Authors' reply (2002) (0)
- Abstract 3581: Predicting Mortality in Acute Coronary Syndromes; A Comparison of the TIMI and GRACE Risk Scores (2007) (0)
- European Society of Cardiology Congress 2013 highlights. (2014) (0)
- Intra-arterial substance P is a potent stimulant for the release of tissue plasminogen activator in the human forearm via a flow independent mechanism (1996) (0)
- DUAL ANTIPLATELET THERAPY AND OUTCOMES IN PATIENTS WITH ATRIAL FIBRILLATION AND ACUTE CORONARY SYNDROMES (2014) (0)
- ASSOCIATION BETWEEN VERY LOW LEVELS OF BASELINE HIGH-DENSITY LIPOPROTEIN CHOLESTEROL AND INCREASED LONG-TERM MORTALITY IN MEDICALLY MANAGED ACUTE CORONARY SYNDROME PATIENTS (2014) (0)
- Chapter 12 – Chronic Stable Angina (2007) (0)
- P2895Evaluation of the effect of oral anticoagulants on all-cause mortality within 3 months of the diagnosis of atrial fibrillation: results from the GARFIELD-AF prospective registry (2018) (0)
- ACS scores: risky business? Authors' reply (2009) (0)
- Differences in the profile and risk of acute coronary syndrome patients stratified by country-level human development index: results from the global TRILOGY ACS trial (2013) (0)
- 128 Implications of lowering the threshold of cardiac troponin in the diagnosis of myocardial infarction (2012) (0)
- Flow cytometric detection of altered platelet function: effects of age and arterial disease (1996) (0)
- Abstract 19943: International Variation in 30-day Unscheduled Cardiovascular Rehospitalization Rates Following Acute Myocardial Infarction in the Global Registry of Acute Coronary Events (GRACE) (2014) (0)
- COMPARISON OF BLEEDING RISK PREDICTION MODELS WITH DUAL ANTI-PLATELET THERAPY TREATMENT AMONG PATIENTS WITH ACUTE CORONARY SYNDROMES TREATED MEDICALLY WITHOUT REVASCULARIZATION (2019) (0)
- A growing need for more research funding in CVD (2015) (0)
- A variant at chromosome 9p21 is associated with recurrent myocardial infarction after acute coronary syndrome: The GRACE Genetics Study (2009) (0)
- Abstract 17504: Time-dependent Association of Circulating microRNAs With Death and Myocardial Infarction After Non-ST Elevation Acute Coronary Syndrome (2016) (0)
- NICE chest pain guidance Reply (2010) (0)
- Wednesday, 29 August 2012 (2012) (0)
- Differential efficacy and safety of oral anticoagulation in atrial fibrillation patients with or without comorbid vascular disease: insights from the GARFIELD-AF registry (2022) (0)
- Chapter 8 – Stable Ischemic Heart Disease/Chronic Stable Angina (2013) (0)
- Abstract 16391: The Impact of Smoking on Clinical Outcomes and the Role of Double-Dose versus Standard-Dose Clopidogrel Among Individuals With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention - Insights From the CURRENT-OASIS 7 Trial (2016) (0)
- Wednesday, 29 August 2012 (2012) (0)
- Interaction of age with gender-stratified survival trajectories in the first year after NSTEMI and STEMI: the Myocardial Ischaemia National Audit Project (MINAP) (2009) (0)
- Low-dose intracoronary alteplase during primary percutaneous coronary intervention in patients with acute myocardial infarction: the T-TIME three-arm RCT (2020) (0)
- What's new for ESC Congress 2013? (Amsterdam 30th August-4th September 2013). (2013) (0)
- Management of acute coronary syndrome (2010) (0)
- Impact of Catheter Shaft Angulation on the Accuracy of Atherosclerotic Plaque Volume Measurement by Three-Dimensional Intravascular Ultrasound (2004) (0)
- The importance of global economic level on AMI outcomes : Data from the Euro Heart Survey 2009 AMI snapshot (2012) (0)
- Lower Limb Vasomotor and Fibrinolytic Effects of Kinin Receptor Agonists in Man (2009) (0)
- Keith Fox: Caledonian collaborations and translational triumphs. (2015) (0)
- 83. Effect of intra-arterial substance P on the release of tissue plasminogen activator in the human forearm (1996) (0)
- Abstract 16169: Individual and Regional Determinants of Time in Therapeutic Range Among Patients Randomized to Warfarin in the ROCKET AF Trial of Rivaroxaban (2011) (0)
- P6432The impact of patterns of long-term conditions on survival among patients with acute myocardial infarction: a national cohort study of 693,333 patients (2017) (0)
- WITHDRAWN: The beautiful study: Baseline characteristics of included patients (2007) (0)
- The United Kingdom's response to the CardioPulse survey questionnaire. (2012) (0)
- Doppler Tissue Imaging for Non-Invasive Optimisation of Graft Functions after Dynamic Cardiomyoplasty (1994) (0)
- Abstract 3998: Patients on Chronic Warfarin Therapy Who Present With an Acute Coronary Syndrome are High Risk and Receive Delayed and Inadequate Treatment (2006) (0)
- 2004 IEEE Ultrasonics Symposium, Vols 1-3 (2004) (0)
- P4603The burden of atrial fibrillation in the more populated European countries: perspectives from the GARFIELD-AF registry (2017) (0)
- Permanent discontinuation of different anticoagulants in patients with atrial fibrillation and the impact on clinical outcome: data from the GARFIELD-AF registry (2020) (0)
- Professor Keith AA Fox. (2016) (0)
- EFFECTS OF PREPUBERTAL HABITATION CONDITIONS ON THE REPRODUCTIVE PHYSIOLOGY OF THE MALE HOUSE MOUSE (2008) (0)
- 238 Is waiting for a coronary angiogram on the weekend safe for NSTEMI patients? Insights from the Canadian Global Registry of acute coronary events (2011) (0)
- Guideline-directed medical therapies for comorbidities among patients with atrial fibrillation: results from GARFIELD-AF (2020) (0)
- Haemoglobin concentration does not predict prognosis in incident (new) cases of heart failure (2003) (0)
- Termination Based on Event Accrual in Per Protocol Versus Intention to Treat in the ROCKET AF Trial (2021) (0)
- Braunwald anginal class as risk factor for the occurrence of early and late clinical events following coronary angioplasty (PTCA) for unstable angina pectoris (UAP) (1996) (0)
- Edinburgh Explorer Relationship of Platelet Reactivity With Bleeding Outcomes During Long-Term Treatment With Dual Antiplatelet Therapy for Medically Managed Patients With Non-ST-Segment Elevation Acute Coronary Syndromes (2018) (0)
- Lower Rates of Heart Failure and Death in Acute Coronary Syndromes—Reply (2007) (0)
- Abstract 16902: Efficacy and Safety of Rivaroxaban versus Warfarin in Patients Taking Non-dihydropyridine Calcium Channel Blockers: Results From the ROCKET AF Trial (2015) (0)
- Healthcare Resource Utilization in Patients with Newly Diagnosed Atrial Fibrillation: A Global Analysis from the GARFIELD-AF Registry (2023) (0)
- Cardiac positron emission tomography: Overview (1990) (0)
- A double blind comparison of enoxaparin (a low molecular weight heparin) with standard heparin in the treatment of unstable coronary artery disease "The essence trial" (1997) (0)
- Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. (2007) (0)
- 23 Performance of the grace 2.0 score in patients with type 1 and type 2 myocardial infarction (2020) (0)
- Abciximab reduced short-term rates of death, MI and repeat revascularization in patients with refractory unstable angina undergoing PTCA. (1997) (0)
- Increased rates of stent thrombosis among patients with acute coronary syndromes: insights from two large oral IIb/IIIa antagonist trials (2001) (0)
- Anomalous origin oftheright coronaryartery fromthepulmonary arteryinassociation with congenital aneurysm ofthesinus ofValsalva: angiographicdiagnosisof a rareassociation (1992) (0)
- 819-6 Inducible nitric oxide synthase activity does not contribute to the maintenance of peripheral vascular tone in patients with symptomatic congestive heart failure (2004) (0)
- Edinburgh Research Explorer Secretory Phospholipase A2-IIA and Cardiovascular Disease (2018) (0)
- 1460Effect of the INR stability characteristics on bleeding events among atrial fibrillation patients undergoing percutaneous coronary intervention: insights from the PIONEER AF-PCI trial (2018) (0)
- Rivaroxaban dosing in patients with atrial fibrillation: results from the RIVER registry – is dosing according to renal function appropriate? (2021) (0)
- P5139Identification of atrial fibrillation patients who are at high bleeding risk after undergoing percutaneous coronary intervention: insights from the PIONEER AF-PCI trial (2018) (0)
- Clinical Perspectives on Lethal Reperfusion Injury (2004) (0)
- Isosorbide dinitrate and furosemide in the treatment of patients with severe pulmonary edema. (1998) (0)
- A profile of Keith AA Fox, cardiologist and researcher. (2014) (0)
- Abstract 4530: Dual Anti-Platelet Therapy in Patients Undergoing Surgery for Critical Limb Ischaemia (2008) (0)
- Comparative effectiveness of NOAC vs VKA in patients representing common clinical challenges: results from the GARFIELD-AF registry (2021) (0)
- Conservative, True Selective Invasive, and Routine Invasive Strategies in Non-ST-Segment Elevation Acute Coronary Syndromes Reply (2010) (0)
- Safety and efficacy of apixaban and rivaroxaban versus warfarin in real-world atrial fibrillation patients are similar to their randomized trials: insights from GARFIELD-AF registry (2021) (0)
- [PP.13.01] THE TREATMENT BENEFIT OF THE ACE-INHIBITOR PERINDOPRIL ON TOP OF BETA-BLOCKER THERAPY IN PATIENTS WITH VASCULAR DISEASE (2016) (0)
- Comparison of the modified Singapore myocardial infarction registry risk score with GRACE 2.0 in predicting 1-year acute myocardial infarction outcomes (2022) (0)
- Characterisation of Access Site Versus Non-Access Site Bleeding After Percutaneous Coronary Intervention in Patients With Atrial Fibrillation (2018) (0)
- Clinical factors associated with peripheral artery disease in patients with documented coronary artery disease: A post hoc analysis of the COMPASS trial. (2021) (0)
- PCV23 Clopidodgrel and Statin Prescribing Patterns in ACS Patients – an Observational Study Using Linked Secondary and Primary Care Data in a UK Population 2003-2009 (2011) (0)
- Thrombolysis in myocardial infarction (1992) (0)
- 1012-127 Neutral endopeptidase inhibition augments the vascular actions of bradykinin in patients with heart failure on chronic angiotensin-converting enzyme inhibitor therapy (2004) (0)
- NICE guidance on the investigation of chest pain Reply (2010) (0)
- The Predictive Power of St Segment Deviation and Recurrent Chest Pain for Identification of Remote Cardiac Events following Unstable Angina (1994) (0)
- The Effects of Rivaroxaban Exposure and Clinical Risk Factors on Efficacy and Safety Outcomes in Patients Treated for Venous Thromboembolism (2017) (0)
- Two-year outcomes of UK patients newly diagnosed with atrial fibrillation: findings from the prospective observational cohort study GARFIELD-AF (2022) (0)
- Abstract 4510: Long-term Clinical Outcomes of an Early Invasive Strategy Compared With a Conservative Strategy for Non-ST-Elevation Acute Coronary Syndromes: A Collaborative Analysis of Individual Patient Data From the FRISC-II, ICTUS, RITA-3 Trials (2009) (0)
- Improved survival is associated with guideline-indicated treatments which persists and is greater for higher risk NSTEMI (2016) (0)
- P3848Why do clinicians withhold anticoagulation in patients with atrial fibrillation and CHA2DS2VASc score of 2 or higher? (2018) (0)
- Abstract 15083: Selective Serotonin Reuptake Inhibitors Increase Bleeding Risk in Anticoagulated Patients With Atrial Fibrillation: An Analysis From the ROCKET AF Trial (2016) (0)
- USE OF DUAL PATHWAY INHIBITION FOR SECONDARY PREVENTION IN PATIENTS WITH ATHEROTHROMBOTIC DISEASE: THE PROSPECTIVE REAL-WORLD XATOA STUDY (2022) (0)
- Abstract 4333: Heterogeneity in Revascularization in Non-ST-elevation Acute Coronary Syndromes and the Effect on Long-term Clinical Outcomes Mortality and Myocardial Infarction: A Collaborative Analysis of Individual Patient Data From the FRISC-II, ICTUS, RITA-3 Trials (2009) (0)
- Current treatment options in the management of stable angina (2008) (0)
- Abstract 13846: The Relationship of Platelet Function Measurements with Bleeding Outcomes During Long-term Treatment with Dual Antiplatelet Therapy in Medically Managed NSTE-ACS Patients (2014) (0)
- Response by Gibson and Fox to Letter Regarding Article, "Recurrent Hospitalization Among Patients With Atrial Fibrillation Undergoing Intracoronary Stenting Treated With 2 Treatment Strategies of Rivaroxaban or a Dose-Adjusted Oral Vitamin K Antagonist Treatment Strategy". (2017) (0)
- Is the relationship of time delay in reperfusion and mortality steeper for fibrinolysis than for primary percutaneous coronary intervention? The global registry of acute coronary events (2005) (0)
- Clinical Risk Prediction Models for the Prognosis and Management of Acute Coronary Syndromes. (2021) (0)
- Abstract 14841: Whole-genome microRNA Sequencing Reveals Circulating microRNAs as High-Risk Markers in Non-ST-Elevation Acute Coronary Syndrome (2016) (0)
- CLINICAL CHARACTERISTICS, MANAGEMENT, AND OUTCOMES OF ACUTE CORONARY SYNDROMES IN RELATION TO RIGHT BUNDLE BRANCH BLOCK ON PRESENTATION (2015) (0)
- Abstract 23086: Impact of Rivaroxaban Alone or in Combination With Aspirin versus Aspirin in Preventing Graft Occlusion in Patients With CABG Surgery COMPASS CABG (2017) (0)
- Variation in access to primary percutaneous coronary intervention in 120 european regions (2013) (0)
- Prognostic significance of electrocardiographic left ventricular hypertrophy and associated st-segment depression in non-st-elevation acute coronary syndromes (2010) (0)
- Heart-Type Fatty Acid-Binding Protein in the Early Diagnosis of Acute Myocardial Infarction (2010) (0)
- 06 Newby.QXD (2001) (0)
- GUIDELINES ON THE MANAGEMENT OF STABLE ANGINA PECTORIS (ENDING) (2007) (0)
- Edinburgh Research Explorer Double-Dose Versus Standard-Dose Clopidogrel According to Smoking Status Among Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention (2017) (0)
- pain Nice guidance on the investigation of chest (2010) (0)
- Letter: Brain natriuretic peptide is a potentially useful screening tool for the detection of cardiovascular disease in patients with rheumatoid arthritis (2006) (0)
- 1 Subsequent Event Risk in Individuals with Established Coronary Heart Disease : Design and Rationale of the GENIUS-CHD Consortium Running title : (2019) (0)
- Gender differences in the use of invasive strategies and recommended medications for AMI in the EHS 2009 snapshot registry (2013) (0)
- Do temporal changes in patient characteristics account for improved outcomes in patients with NSTEMI? A population-based cohort study (2016) (0)
- Abstract 19512: Characterization of Access vs. Non-Access Site Bleeding Following PCI in Patients With Atrial Fibrillation (2017) (0)
- Two-year outcomes of patients with atrial fibrillation treated with rivaroxaban: results from RIVER registry (2021) (0)
- Benzodiazepines, reproduction, and development. (1975) (0)
- P6433Association between optimal guideline-indicated care and survival in patients with acute myocardial infarction and long-term conditions: a population based cohort study (2017) (0)
- Relationship Between Resuscitator Skill Level and In-Hospital Mortality After Out-of-Hospital Cardiac Arrest (1995) (0)
- Abstract 16866: Blood Pressure Control and Stroke or Bleeding Risk in Patients with Atrial Fibrillation: Results from the ROCKET AF Trial (2014) (0)
- Long-term of atherothrombosis (2004) (0)
- 024 IMPACT OF MISSED OPPORTUNITIES OF HOSPITAL CARE FOR ST-ELEVATION MYOCARDIAL INFARCTION ON MORTALITY, MYOCARDIAL ISCHAEMIA NATIONAL AUDIT PROJECT (MINAP) 2008–2009 (2013) (0)
- 249High-sensitivity cardiac troponin and the universal definition of myocardial infarction: a randomised controlled trial (2019) (0)
- Acute coronary syndromes produce increased levels of platelet-monocyte binding: Possible novel mechanisms in vascular injury (2003) (0)
- Dual Anti-Platelet Therapy in Patients Undergoing Surgery for Critical Limb Ischaemia (2008) (0)
- Bleeding events with lytics and thienopyridines in patients with ST-segment elevation myocardial infarction: insights from a large clinical practice registry (2004) (0)
- The Year in Cardiology series: the most recent advances in a nutshell for the readers of the European Heart Journal. (2013) (0)
- High frequency ultrasonic imaging and attachment of contrast agents under flow conditions (2005) (0)
- TIME-TRENDS IN ANTITHROMBOTIC MANAGEMENT OF PATIENTS WITH AF/FLUTTER TREATED WITH CORONARY STENTS: AN INTERNATIONAL MULTICENTER RESTROSPECTIVE ANALYSIS (2017) (0)
- Abstract 12130: Outcomes in Women Compared With Men in Patients With Unstable Angina/Non-ST-Segment Elevation Myocardial Infarction Managed Without Revascularization: Insights From the TRILOGY ACS Trial (2013) (0)
- Out-of-hospital cardiac arrest survivors: Effect of cerebral anoxia on cognitive and motor speed and visual information processing (2000) (0)
- The Thrombosis Research Institute, London. (2019) (0)
- Use and outcomes of dual antiplatelet therapy for acute coronary syndrome in patients with chronic kidney disease: insights from the Canadian Observational Antiplatelet Study (COAPT) (2022) (0)
- 2180Estimating individual lifetime benefit and bleeding risk of adding rivaroxaban to aspirin for patients with stable cardiovascular disease: results from the COMPASS trial (2019) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Keith Fox?
Keith Fox is affiliated with the following schools: